UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One) | | | | | |
x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2023March 31, 2024
OR | | | | | |
¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-10258
Tredegar Corporation
(Exact Name of Registrant as Specified in Its Charter)
| | | | | | | | |
Virginia | | 54-1497771 |
(State or Other Jurisdiction of Incorporation or Organization) | | (I.R.S. Employer Identification No.) |
| | | | | | | | | | | |
1100 Boulders Parkway | | |
Richmond, | Virginia | | 23225 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (804) 330-1000
Securities registered pursuant to Section 12(b) of the Act: | | | | | | | | |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common stock, no par value | TG | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. | | | | | | | | | | | | | | | | | | | | | | | |
Large accelerated filer | | ¨ | Accelerated filer | x | Smaller reporting company | | ☐ |
| | | | | |
Non-accelerated filer | | ¨ | | Emerging growth company | | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No x
The number of shares of Common Stock, no par value, outstanding as of August 4, 2023: 34,384,677May 3, 2024: 34,484,893
Tredegar Corporation
Table of Contents
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
Tredegar Corporation
Condensed Consolidated Balance Sheets
(In Thousands, Except Share Data)
(Unaudited) | | June 30, | | December 31, |
| 2023 | | 2022 |
| March 31, | | | March 31, | | December 31, |
| 2024 | | | 2024 | | 2023 |
Assets | Assets | |
Current assets: | Current assets: | |
Current assets: | |
Current assets: | |
Cash and cash equivalents | Cash and cash equivalents | $ | 21,193 | | | $ | 19,232 | |
Cash and cash equivalents | |
Cash and cash equivalents | |
Restricted cash | |
Accounts and other receivables, net | Accounts and other receivables, net | 79,139 | | | 84,544 | |
Income taxes recoverable | Income taxes recoverable | 1,216 | | | 733 | |
Inventories | Inventories | 86,692 | | | 127,771 | |
Prepaid expenses and other | Prepaid expenses and other | 10,214 | | | 10,304 | |
Total current assets | Total current assets | 198,454 | | | 242,584 | |
Property, plant and equipment, at cost | Property, plant and equipment, at cost | 545,048 | | | 531,921 | |
Less: accumulated depreciation | Less: accumulated depreciation | (355,156) | | | (345,510) | |
Net property, plant and equipment | Net property, plant and equipment | 189,892 | | | 186,411 | |
Right-of-use leased assets | Right-of-use leased assets | 12,794 | | | 14,021 | |
Identifiable intangible assets, net | Identifiable intangible assets, net | 10,785 | | | 11,690 | |
Goodwill | Goodwill | 55,195 | | | 70,608 | |
Deferred income taxes | Deferred income taxes | 14,610 | | | 13,900 | |
Other assets | Other assets | 3,139 | | | 2,879 | |
Total assets | Total assets | $ | 484,869 | | | $ | 542,093 | |
Liabilities and Shareholders’ Equity | Liabilities and Shareholders’ Equity | |
Current liabilities: | Current liabilities: | |
Current liabilities: | |
Current liabilities: | |
Accounts payable | |
Accounts payable | |
Accounts payable | Accounts payable | $ | 82,290 | | | $ | 114,938 | |
Accrued expenses | Accrued expenses | 23,501 | | | 31,603 | |
Lease liability, short-term | Lease liability, short-term | 2,163 | | | 2,035 | |
ABL revolving facility (matures June 30, 2026) | |
Income taxes payable | Income taxes payable | 579 | | | 1,137 | |
Total current liabilities | Total current liabilities | 108,533 | | | 149,713 | |
Lease liability, long-term | Lease liability, long-term | 11,991 | | | 12,738 | |
Long-term debt | Long-term debt | 141,000 | | | 137,000 | |
Pension and other postretirement benefit obligations, net | Pension and other postretirement benefit obligations, net | 35,747 | | | 35,046 | |
| Other non-current liabilities | Other non-current liabilities | 4,449 | | | 5,834 | |
Other non-current liabilities | |
Other non-current liabilities | |
Total liabilities | Total liabilities | 301,720 | | | 340,331 | |
Shareholders’ equity: | Shareholders’ equity: | |
Common stock, no par value (authorized shares 150,000,000, issued and outstanding 34,363,845 shares at June 30, 2023 and 34,000,642 shares at December 31, 2022) | 60,078 | | | 58,824 | |
Common stock held in trust for savings restoration plan (116,336 shares at June 30, 2023 and 113,316 shares at December 31, 2022) | (2,218) | | | (2,188) | |
Common stock, no par value (authorized shares 150,000,000, issued and outstanding 34,533,870 shares at March 31, 2024 and 34,408,638 shares at December 31, 2023) | |
Common stock, no par value (authorized shares 150,000,000, issued and outstanding 34,533,870 shares at March 31, 2024 and 34,408,638 shares at December 31, 2023) | |
Common stock, no par value (authorized shares 150,000,000, issued and outstanding 34,533,870 shares at March 31, 2024 and 34,408,638 shares at December 31, 2023) | |
Common stock held in trust for savings restoration plan (118,543 shares at March 31, 2024 and 118,543 shares at December 31, 2023) | |
Accumulated other comprehensive income (loss): | Accumulated other comprehensive income (loss): | |
Foreign currency translation adjustment | |
Foreign currency translation adjustment | |
Foreign currency translation adjustment | Foreign currency translation adjustment | (83,338) | | | (86,079) | |
Gain (loss) on derivative financial instruments | Gain (loss) on derivative financial instruments | (843) | | | (2,480) | |
Pension and other postretirement benefit adjustments | Pension and other postretirement benefit adjustments | (54,463) | | | (59,036) | |
Retained earnings | Retained earnings | 263,933 | | | 292,721 | |
Total shareholders’ equity | Total shareholders’ equity | 183,149 | | | 201,762 | |
Total liabilities and shareholders’ equity | Total liabilities and shareholders’ equity | $ | 484,869 | | | $ | 542,093 | |
See accompanying notes to the condensed consolidated financial statements.
Tredegar Corporation
Condensed Consolidated Statements of Income (Loss)
(In Thousands, Except Per Share Data)
(Unaudited)
| | Three Months Ended March 31, | |
| Three Months Ended March 31, | |
| Three Months Ended March 31, | |
| | | Three Months Ended June 30, | | Six Months Ended June 30, |
| | 2023 | | 2022 | | 2023 | | 2022 |
Revenues and other items: | Revenues and other items: | |
Revenues and other items: | |
Revenues and other items: | |
Sales | |
Sales | |
Sales | Sales | $ | 178,167 | | | $ | 274,363 | | | $ | 369,289 | | | $ | 510,929 | |
Other income (expense), net | Other income (expense), net | (20) | | | 1,342 | | | 260 | | | 1,041 | |
| 178,147 | | | 275,705 | | | 369,549 | | | 511,970 | |
Other income (expense), net | |
Other income (expense), net | |
| 175,744 | |
| 175,744 | |
| 175,744 | |
Costs and expenses: | |
Costs and expenses: | |
Costs and expenses: | Costs and expenses: | |
Cost of goods sold | Cost of goods sold | 153,267 | | | 218,088 | | | 312,792 | | | 401,348 | |
Cost of goods sold | |
Cost of goods sold | |
Freight | |
Freight | |
Freight | Freight | 7,199 | | | 11,036 | | | 13,243 | | | 19,118 | |
Selling, general and administrative | Selling, general and administrative | 16,889 | | | 18,862 | | | 35,894 | | | 40,143 | |
Selling, general and administrative | |
Selling, general and administrative | |
Research and development | |
Research and development | |
Research and development | Research and development | 1,376 | | | 1,754 | | | 2,581 | | | 3,278 | |
Amortization of identifiable intangibles | Amortization of identifiable intangibles | 464 | | | 666 | | | 968 | | | 1,329 | |
Amortization of identifiable intangibles | |
Amortization of identifiable intangibles | |
Pension and postretirement benefits | |
Pension and postretirement benefits | |
Pension and postretirement benefits | Pension and postretirement benefits | 3,418 | | | 3,506 | | | 6,837 | | | 6,982 | |
Interest expense | Interest expense | 2,374 | | | 1,234 | | | 4,686 | | | 2,020 | |
Interest expense | |
Interest expense | |
Asset impairments and costs associated with exit and disposal activities, net of adjustments | Asset impairments and costs associated with exit and disposal activities, net of adjustments | — | | | 134 | | | 69 | | | 126 | |
Goodwill impairment | 15,413 | | | — | | | 15,413 | | | — | |
Asset impairments and costs associated with exit and disposal activities, net of adjustments | |
Asset impairments and costs associated with exit and disposal activities, net of adjustments | |
| Total | |
| Total | |
| Total | Total | 200,400 | | | 255,280 | | | 392,483 | | | 474,344 | |
Income (loss) before income taxes | Income (loss) before income taxes | (22,253) | | | 20,425 | | | (22,934) | | | 37,626 | |
Income (loss) before income taxes | |
Income (loss) before income taxes | |
Income tax expense (benefit) | Income tax expense (benefit) | (3,331) | | | 5,556 | | | (3,000) | | | 6,334 | |
Income tax expense (benefit) | |
Income tax expense (benefit) | |
Net income (loss) | |
Net income (loss) | |
Net income (loss) | Net income (loss) | $ | (18,922) | | | $ | 14,869 | | | $ | (19,934) | | | $ | 31,292 | |
| Earnings (loss) per share: | Earnings (loss) per share: | |
| Earnings (loss) per share: | |
| Earnings (loss) per share: | |
Basic | Basic | $ | (0.56) | | | $ | 0.44 | | | $ | (0.59) | | | $ | 0.93 | |
Basic | |
Basic | |
Diluted | |
Diluted | |
Diluted | Diluted | $ | (0.56) | | | $ | 0.44 | | | $ | (0.59) | | | $ | 0.93 | |
| Shares used to compute earnings (loss) per share: | Shares used to compute earnings (loss) per share: | |
| Shares used to compute earnings (loss) per share: | |
| Shares used to compute earnings (loss) per share: | |
Basic | |
Basic | |
Basic | Basic | 34,079 | | | 33,814 | | | 33,988 | | | 33,734 | |
Diluted | Diluted | 34,079 | | | 33,854 | | | 33,988 | | | 33,776 | |
Diluted | |
Diluted | |
See accompanying notes to the condensed consolidated financial statements.
Tredegar Corporation
Condensed Consolidated Statements of Comprehensive Income (Loss)
(In Thousands)
(Unaudited)
| | Three Months Ended June 30, |
| Three Months Ended March 31, | | | Three Months Ended March 31, |
| | 2023 | | 2022 | | 2024 | | 2023 |
Net income (loss) | Net income (loss) | $ | (18,922) | | | $ | 14,869 | |
Other comprehensive income (loss): | Other comprehensive income (loss): | |
Unrealized foreign currency translation adjustment (net of tax expense of $179 in 2023 and net of tax benefit of $482 in 2022) | 1,621 | | | (5,230) | |
Derivative financial instruments adjustment (net of tax expense of $500 in 2023 and net of tax benefit of $3,359 in 2022) | 368 | | | (9,161) | |
Amortization of prior service costs and net gains or losses (net of tax expense of $637 in 2023 and net of tax expense of $712 in 2022) | 2,286 | | | 2,556 | |
Unrealized foreign currency translation adjustment (net of tax expense of $221 in 2024 and net of tax expense of $436 in 2023) | |
Unrealized foreign currency translation adjustment (net of tax expense of $221 in 2024 and net of tax expense of $436 in 2023) | |
Unrealized foreign currency translation adjustment (net of tax expense of $221 in 2024 and net of tax expense of $436 in 2023) | |
Derivative financial instruments adjustment (net of tax benefit of $140 in 2024 and net of tax expense of $836 in 2023) | |
Amortization of prior service costs and net gains or losses (net of tax benefit of $8 in 2024 and net of tax expense of $637 in 2023) | |
Other comprehensive income (loss) | Other comprehensive income (loss) | 4,275 | | | (11,835) | |
Comprehensive income (loss) | Comprehensive income (loss) | $ | (14,647) | | | $ | 3,034 | |
| | | | | | | | | | | |
| Six Months Ended June 30, |
| 2023 | | 2022 |
Net income (loss) | $ | (19,934) | | | $ | 31,292 | |
Other comprehensive income (loss): | | | |
Unrealized foreign currency translation adjustment (net of tax expense of $615 in 2023 and net of tax expense of $246 in 2022) | 2,741 | | | 306 | |
Derivative financial instruments adjustment (net of tax expense of $1,336 in 2023 and net of tax benefit of $443 in 2022) | 1,637 | | | (3,231) | |
Amortization of prior service costs and net gains or losses (net of tax expense of $1,274 in 2023 and net of tax expense of $1,424 in 2022) | 4,573 | | | 5,094 | |
Other comprehensive income (loss) | 8,951 | | | 2,169 | |
Comprehensive income (loss) | $ | (10,983) | | | $ | 33,461 | |
See accompanying notes to the condensed consolidated financial statements.
Tredegar Corporation
Condensed Consolidated Statements of Cash Flows
(In Thousands)
(Unaudited) | | Six Months Ended June 30, |
| 2023 | | 2022 |
| Three Months Ended March 31, | | | Three Months Ended March 31, |
| 2024 | | | 2024 | | 2023 |
Cash flows from operating activities: | Cash flows from operating activities: | |
Net income (loss) | |
Net income (loss) | |
Net income (loss) | Net income (loss) | $ | (19,934) | | | $ | 31,292 | |
Adjustments for noncash items: | Adjustments for noncash items: | |
Depreciation | Depreciation | 12,387 | | | 11,536 | |
Depreciation | |
Depreciation | |
Amortization of identifiable intangibles | Amortization of identifiable intangibles | 968 | | | 1,329 | |
Reduction of right-of-use lease asset | Reduction of right-of-use lease asset | 1,075 | | | 1,072 | |
Goodwill impairment | 15,413 | | | — | |
| Deferred income taxes | |
Deferred income taxes | |
Deferred income taxes | Deferred income taxes | (3,731) | | | 2,516 | |
Accrued pension and post-retirement benefits | Accrued pension and post-retirement benefits | 6,837 | | | 7,013 | |
| Stock-based compensation expense | |
Stock-based compensation expense | |
Stock-based compensation expense | Stock-based compensation expense | 521 | | | 1,842 | |
Gain on investment in kaléo | Gain on investment in kaléo | (262) | | | (1,406) | |
| Changes in assets and liabilities: | Changes in assets and liabilities: | |
Changes in assets and liabilities: | |
Changes in assets and liabilities: | |
Accounts and other receivables | |
Accounts and other receivables | |
Accounts and other receivables | Accounts and other receivables | 6,190 | | | (24,172) | |
Inventories | Inventories | 43,013 | | | (31,495) | |
Income taxes recoverable/payable | Income taxes recoverable/payable | (1,060) | | | (6,129) | |
Prepaid expenses and other | Prepaid expenses and other | 2,976 | | | (516) | |
Accounts payable and accrued expenses | Accounts payable and accrued expenses | (39,629) | | | 47,388 | |
Lease liability | Lease liability | (1,095) | | | (1,166) | |
Pension and postretirement benefit plan contributions | Pension and postretirement benefit plan contributions | (279) | | | (50,314) | |
Other, net | Other, net | (692) | | | 1,781 | |
Net cash provided by (used in) operating activities | Net cash provided by (used in) operating activities | 22,698 | | | (9,429) | |
Cash flows from investing activities: | Cash flows from investing activities: | |
Capital expenditures | Capital expenditures | (15,907) | | | (13,514) | |
Capital expenditures | |
Capital expenditures | |
Proceeds from the sale of kaléo | Proceeds from the sale of kaléo | 262 | | | 1,406 | |
| Proceeds from the sale of assets | |
Net cash provided by (used in) investing activities | Net cash provided by (used in) investing activities | (15,645) | | | (12,108) | |
Cash flows from financing activities: | Cash flows from financing activities: | |
Borrowings | Borrowings | 41,250 | | | 221,250 | |
Borrowings | |
Borrowings | |
Debt principal payments | Debt principal payments | (37,250) | | | (192,750) | |
Dividends paid | Dividends paid | (8,884) | | | (8,135) | |
Debt financing costs | — | | | (1,245) | |
Other | — | | | (396) | |
| Net cash provided by (used in) financing activities | |
| Net cash provided by (used in) financing activities | |
| Net cash provided by (used in) financing activities | Net cash provided by (used in) financing activities | (4,884) | | | 18,724 | |
Effect of exchange rate changes on cash | Effect of exchange rate changes on cash | (208) | | | (246) | |
Increase (decrease) in cash & cash equivalents | 1,961 | | | (3,059) | |
Cash and cash equivalents at beginning of period | 19,232 | | | 30,521 | |
Cash and cash equivalents at end of period | $ | 21,193 | | | $ | 27,462 | |
Increase (decrease) in cash, cash equivalents and restricted cash | |
Cash, cash equivalents and restricted cash at beginning of period | |
Cash, cash equivalents and restricted cash at end of period | |
See accompanying notes to the condensed consolidated financial statements.
Tredegar Corporation
Condensed Consolidated Statements of Shareholders’ Equity
(In Thousands, Except Share and Per Share Data)
(Unaudited)
The following summarizes the changes in shareholders’ equity for the three month period ended June 30, 2023:March 31, 2024:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity |
Balance April 1, 2023 | $ | 59,423 | | | $ | 287,308 | | | $ | (2,203) | | | $ | (142,919) | | | $ | 201,609 | |
Net income (loss) | — | | | (18,922) | | | — | | | — | | | (18,922) | |
Foreign currency translation adjustment | — | | | — | | | — | | | 1,621 | | | 1,621 | |
Derivative financial instruments adjustment | — | | | — | | | — | | | 368 | | | 368 | |
Amortization of prior service costs and net gains or losses | — | | | — | | | — | | | 2,286 | | | 2,286 | |
Cash dividends declared ($0.13 per share) | — | | | (4,468) | | | — | | | — | | | (4,468) | |
Stock-based compensation expense | 655 | | | — | | | — | | | — | | | 655 | |
| | | | | | | | | |
Tredegar common stock purchased by trust for savings restoration plan | — | | | 15 | | | (15) | | | — | | | — | |
Balance June 30, 2023 | $ | 60,078 | | | $ | 263,933 | | | $ | (2,218) | | | $ | (138,644) | | | $ | 183,149 | |
The following summarizes the changes in shareholders’ equity for the six month period ended June 30, 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity |
Balance January 1, 2023 | $ | 58,824 | | | $ | 292,721 | | | $ | (2,188) | | | $ | (147,595) | | | $ | 201,762 | |
Net income (loss) | — | | | (19,934) | | | — | | | — | | | (19,934) | |
Foreign currency translation adjustment | — | | | — | | | — | | | 2,741 | | | 2,741 | |
Derivative financial instruments adjustment | — | | | — | | | — | | | 1,637 | | | 1,637 | |
Amortization of prior service costs and net gains or losses | — | | | — | | | — | | | 4,573 | | | 4,573 | |
Cash dividends declared ($0.26 per share) | — | | | (8,884) | | | — | | | — | | | (8,884) | |
Stock-based compensation expense | 1,508 | | | — | | | — | | | — | | | 1,508 | |
Repurchase of employee common stock for tax withholdings | (254) | | | — | | | — | | | — | | | (254) | |
Tredegar common stock purchased by trust for savings restoration plan | — | | | 30 | | | (30) | | | — | | | — | |
Balance June 30, 2023 | $ | 60,078 | | | $ | 263,933 | | | $ | (2,218) | | | $ | (138,644) | | | $ | 183,149 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity |
Balance January 1, 2024 | $ | 61,606 | | | $ | 177,977 | | | $ | (2,233) | | | $ | (81,697) | | | $ | 155,653 | |
Net income (loss) | — | | | 3,288 | | | — | | | — | | | 3,288 | |
Foreign currency translation adjustment | — | | | — | | | — | | | (1,948) | | | (1,948) | |
Derivative financial instruments adjustment | — | | | — | | | — | | | (504) | | | (504) | |
Amortization of prior service costs and net gains or losses | — | | | — | | | — | | | (27) | | | (27) | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
Stock-based compensation expense | 579 | | | — | | | — | | | — | | | 579 | |
Repurchase of employee common stock for tax withholdings | (226) | | | — | | | — | | | — | | | (226) | |
| | | | | | | | | |
Balance March 31, 2024 | $ | 61,959 | | | $ | 181,265 | | | $ | (2,233) | | | $ | (84,176) | | | $ | 156,815 | |
The following summarizes the changes in shareholders’ equity for the three month period ended June 30, 2022:March 31, 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity |
Balance at April 1, 2022 | $ | 55,953 | | | $ | 293,563 | | | $ | (2,148) | | | $ | (135,500) | | | $ | 211,868 | |
Net income (loss) | — | | | 14,869 | | | — | | | — | | | 14,869 | |
Foreign currency translation adjustment | — | | | — | | | — | | | (5,230) | | | (5,230) | |
Derivative financial instruments adjustment | — | | | — | | | — | | | (9,161) | | | (9,161) | |
Amortization of prior service costs and net gains or losses | — | | | — | | | — | | | 2,556 | | | 2,556 | |
Cash dividends declared ($0.12 per share) | — | | | (4,075) | | | — | | | — | | | (4,075) | |
Stock-based compensation expense | 958 | | | — | | | — | | | — | | | 958 | |
Tredegar common stock purchased by trust for savings restoration plan | — | | | 13 | | | (13) | | | — | | | — | |
Balance at June 30, 2022 | $ | 56,911 | | | $ | 304,370 | | | $ | (2,161) | | | $ | (147,335) | | | $ | 211,785 | |
The following summarizes the changes in shareholders’ equity for the six month period ended June 30, 2022: | | | Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity | | Common Stock | | Retained Earnings | | Trust for Savings Restoration Plan | | Accumulated Other Comprehensive Income (Loss) | | Total Shareholders’ Equity |
Balance at January 1, 2022 | $ | 55,174 | | | $ | 281,187 | | | $ | (2,135) | | | $ | (149,504) | | | $ | 184,722 | |
Balance at January 1, 2023 | |
Net income (loss) | Net income (loss) | — | | | 31,292 | | | — | | | — | | | 31,292 | |
Foreign currency translation adjustment | Foreign currency translation adjustment | — | | | — | | | — | | | 306 | | | 306 | |
Derivative financial instruments adjustment | Derivative financial instruments adjustment | — | | | — | | | — | | | (3,231) | | | (3,231) | |
Amortization of prior service costs and net gains or losses | Amortization of prior service costs and net gains or losses | — | | | — | | | — | | | 5,094 | | | 5,094 | |
Cash dividends declared ($0.24 per share) | — | | | (8,135) | | | — | | | — | | | (8,135) | |
Cash dividends declared ($0.13 per share) | |
Stock-based compensation expense | Stock-based compensation expense | 2,133 | | | — | | | — | | | — | | | 2,133 | |
Repurchase of employee common stock for tax withholdings | Repurchase of employee common stock for tax withholdings | (396) | | | — | | | — | | | — | | | (396) | |
Tredegar common stock purchased by trust for savings restoration plan | Tredegar common stock purchased by trust for savings restoration plan | — | | | 26 | | | (26) | | | — | | | — | |
Balance at June 30, 2022 | $ | 56,911 | | | $ | 304,370 | | | $ | (2,161) | | | $ | (147,335) | | | $ | 211,785 | |
Balance at March 31, 2023 | |
See accompanying notes to the condensed consolidated financial statements.
TREDEGAR CORPORATION
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. BASIS OF PRESENTATION
In the opinion of management, the accompanying condensed consolidated financial statements of Tredegar Corporation and its subsidiaries (“Tredegar,” “the Company,” “we,” “us” or “our”) contain all adjustments necessary to state fairly, in all material respects, Tredegar’s condensed consolidated financial position as of June 30, 2023,March 31, 2024, the condensed consolidated results of operations for the three and six months ended June 30,March 31, 2024 and 2023, and 2022, the condensed consolidated cash flows for the sixthree months ended June 30,March 31, 2024 and 2023, and 2022, and the condensed consolidated changes in shareholders’ equity for the sixthree months ended June 30,March 31, 2024 and 2023, and 2022, in accordance with U.S. generally accepted accounting principles (“GAAP”). All such adjustments, unless otherwise detailed in the notes to the condensed consolidated financial statements, are deemed to be of a normal, recurring nature.
The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which operates on a 52/53-week fiscal year basis. As such, the fiscal secondfirst quarter for 20232024 and 20222023 for this segment references 13-week periods ended June 25,March 31, 2024 and March 26, 2023, and June 26, 2022, respectively. The Company does not believe the impact of reporting the results of this segment as stated above is material to the consolidated financial results. The Company may fund or receive cash from the Aluminum Extrusions segment based on Aluminum Extrusion’s cash flows from operations during the intervening period from Aluminum Extrusion’s fiscal quarter end and the Company’s fiscal quarter end. There was no intercompany funding with Aluminum Extrusions between June 25, 2023 and June 30, 2023.
The condensed consolidated financial statements as of December 31, 20222023 that is included herein was derived from the audited consolidated financial statements provided in the Company’s Annual Report on Form 10-K for the year ended December 31, 20222023 (“20222023 Form 10-K”) but does not include all disclosures required by GAAP. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in the 20222023 Form 10-K.
The results of operations for the three and six months ended June 30, 2023,March 31, 2024, are not necessarily indicative of the results to be expected for the full year.
ImpairmentSale of GoodwillFlexible Packaging Films
The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). As of June 30,On September 1, 2023, the Company’s reporting units with goodwill were Surface Protection in PECompany announced that it had entered into a definitive agreement to sell its Flexible Packaging Films ("Surface Protection"business (also referred to as "Terphane") and Futura in Aluminum Extrusions (“Futura”to Oben Group (the “Contingent Terphane Sale”). No events or circumstances were identified during the second quarter of 2023 that indicate that Futura’s fair value is more likely than not less than its carrying amount.
However, manufacturers in the supply chain for consumer electronics continue to experience reduced capacity utilization and inventory corrections. In lightCompletion of the continued uncertainty aboutsale is contingent upon the timingsatisfaction of a recovery for this marketcustomary closing conditions, including the receipt of certain competition filing approvals by authorities in Brazil and the expected adverse future impact to the Surface Protection business,Colombia. On October 27, 2023, the Company performed a Step 1 goodwill impairment analysis offiled the Surface Protection componentrequisite competition forms with the Administrative Council for Economic Defense (“CADE”) in Brazil. The regulatory review process is ongoing and in line with the Company’s expectations. CADE’s maximum deadline for completing its review is no later than November 18, 2024. The merger review regarding the transaction was cleared by the Colombian authority in early February 2024.
Closure of PE Films using projectionsTechnical Center
In August 2023, the Company adopted a plan to close the PE Films technical center in Richmond, VA and reduce its efforts to develop and sell films supporting the semiconductor market. Future research & development activities for PE Films will be performed at the production facility in Pottsville, PA. PE Films continues to have new business opportunities primarily relating to surface protection films that contemplateprotect components of flat panel and flexible displays. All activities ceased at the expected market recovery and business conditions,PE Films technical center in Richmond, VA as these events indicated Surface Protection’s fair value is more likely than not less than its carrying amount.
of the end of the first quarter of 2024. The Company estimated the fair value of Surface Protection at June 30, 2023 by: (i) computing an estimated enterprise value (“EV”) utilizing the discounted cash flow method (the “DCF Method”), (ii) applying adjustments for any surplus or deficient working capital, (iii) adding cash and cash equivalents, and (iv) subtracting interest-bearing debt. The DCF Method was used since Surface Protection’s projections reflect the expected recovery from the weak market demand, competitive pricing and cash flowsrecognized expense incurred through March 31, 2024 associated with new surface protection products, applications, customers, production efficiencies, and cost savings.
The analysis concluded that the fair valueexit activities of Surface Protection was less than its carrying value, thus$0.2 million for building closure costs. In addition, the Company recognized a non-cash partial goodwill impairment of $15.4 millionloss on the lease abandonment ($11.9 million after deferred income tax benefits) was recognized during the second quarter of 2023.
Given the uncertain demand for Surface Protections products, it is reasonably possible that the cash flow estimates used in deriving such fair value measurements may change in the future. The Surface Protection reporting unit had goodwill of $41.9 million and $57.3 million as of June 30, 2023 and December 31, 2022, respectively.
0.3 million).
Supply Chain Financing
As of March 31, 2024 and December 31, 2023, $8.8 million and $15.8 million, respectively, of the Company’s accounts payable were financed by participating suppliers through third-party financial institutions.
Accounting Standards Adoptedstandards not yet adopted
No Accounting Standard Updates issued byIn October 2023, the Financial Accounting Standards Board were adopted during("FASB") issued Accounting Standards Update ("ASU") 2023-06 to amend various paragraphs in the second quarterAccounting Standards Codification ("ASC") to primarily reflect the issuance of 2023.U.S. Securities and Exchange Commission ("SEC") Staff Bulletin No. 33-10532. ASU 2023-06 will impact various disclosure areas, including the statement of cash flows, accounting changes and error corrections, earnings per share, debt, equity, derivatives, and transfers of financial assets. The amendments in this ASU 2023-06 will be effective on the date the related disclosures are removed from Regulation S-X or Regulation S-K by the SEC and will no longer be effective if the SEC has not removed the applicable disclosure requirement by June 30, 2027. Early adoption is not permitted. The Company does not expect a material impact from the adoption of this standard on our consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07 to improve reportable segment disclosure and requirements, primarily through the enhanced disclosures about significant segment expenses. ASU 2023-07 expands public entities’ segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment’s profit or loss and assets. This ASU is effective for fiscal years beginning after December 15, 2023 and interim period beginning after December 15, 2024, with early adoption permitted. The amendments in this ASU are to be applied retrospectively to all prior periods presented in the financial statements. The Company is currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09 to improve the income tax disclosures related to the rate reconciliation and income taxes paid information and to improve the effectiveness of income tax disclosures. The amendments in this ASU will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024; early adoption is permitted.The Company is currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.
2. ACCOUNTS AND OTHER RECEIVABLES
As of June 30, 2023March 31, 2024 and December 31, 2022,2023, accounts receivable and other receivables, net include the following: | (In thousands) | (In thousands) | June 30, 2023 | | December 31, 2022 | (In thousands) | March 31, 2024 | | December 31, 2023 |
Customer receivables | Customer receivables | $ | 79,112 | | | $ | 83,667 | |
Other receivables | Other receivables | 2,233 | | | 3,874 | |
Total accounts and other receivables | Total accounts and other receivables | 81,345 | | | 87,541 | |
Less: Allowance for bad debts | Less: Allowance for bad debts | (2,206) | | | (2,997) | |
Total accounts and other receivables, net | Total accounts and other receivables, net | $ | 79,139 | | | $ | 84,544 | |
3. INVENTORIES
The components of inventories are as follows: | (In thousands) | (In thousands) | June 30, 2023 | | December 31, 2022 | (In thousands) | March 31, 2024 | | December 31, 2023 |
Finished goods | Finished goods | $ | 29,677 | | | $ | 34,686 | |
Work-in-process | Work-in-process | 12,678 | | | 15,604 | |
Raw materials | Raw materials | 23,897 | | | 58,262 | |
Stores, supplies and other | Stores, supplies and other | 20,440 | | | 19,219 | |
Total | Total | $ | 86,692 | | | $ | 127,771 | |
4. PENSION AND OTHER POSTRETIREMENT BENEFITS
Tredegar sponsorssponsored a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan. In connection therewith, on February 9, 2022,plan through lump sum distributions and the Company contributed $50 million topurchase of annuity contracts. On November 3, 2023, the pension plan (the “Special Contribution”). Thetermination and settlement process for the Company estimates that, withwas completed, and the Special Contribution, there will be no required minimum contributions to theremaining pension plan until final settlement.obligation was transferred to Massachusetts Mutual Life Insurance Company. During 2023, the Company recognized a pre-tax pension settlement loss of $92.3 million.
Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. Pension expense recognized for this plan was immaterial in the three and six months ended June 30, 2023March 31, 2024 and 2022.2023. This information has been included in the pension benefit table below.
The components of net periodic benefit cost for the pension and other postretirement benefit programs reflected in the condensed consolidated statements of income for the three and six months ended June 30,March 31, 2024 and 2023, and 2022, are shown below: | | Pension Benefits | | Other Post-Retirement Benefits |
| Pension Benefits | | | Pension Benefits | | Other Post-Retirement Benefits |
| | Three Months Ended June 30, | | Three Months Ended June 30, | | Three Months Ended March 31, | | Three Months Ended March 31, |
(In thousands) | (In thousands) | 2023 | | 2022 | | 2023 | | 2022 | (In thousands) | 2024 | | 2023 | | 2024 | | 2023 |
Service cost | Service cost | $ | — | | | $ | — | | | $ | 3 | | | $ | 5 | |
Interest cost | Interest cost | 3,028 | | | 2,225 | | | 71 | | | 51 | |
Expected return on plan assets | Expected return on plan assets | (2,607) | | | (2,043) | | | — | | | — | |
Amortization of prior service costs, (gains) losses and net transition asset | Amortization of prior service costs, (gains) losses and net transition asset | 2,982 | | | 3,302 | | | (59) | | | (34) | |
Net periodic benefit cost | Net periodic benefit cost | $ | 3,403 | | | $ | 3,484 | | | $ | 15 | | | $ | 22 | |
| | | Pension Benefits | | Other Post-Retirement Benefits |
| | Six Months Ended June 30, | | Six Months Ended June 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Service cost | $ | — | | | $ | — | | | $ | 6 | | | $ | 10 | |
Interest cost | 6,056 | | | 4,450 | | | 142 | | | 102 | |
Expected return on plan assets | (5,214) | | | (4,098) | | | — | | | — | |
Amortization of prior service costs, (gains) losses and net transition asset | 5,965 | | | 6,586 | | | (118) | | | (68) | |
Net periodic benefit cost | $ | 6,807 | | | $ | 6,938 | | | $ | 30 | | | $ | 44 | |
|
Pension and other postretirement liabilities were $36.4$7.2 million and $35.7$7.3 million at June 30, 2023March 31, 2024 and December 31, 2022,2023, respectively ($0.70.6 million and $0.7 million included in “Accrued expenses” at June 30, 2023March 31, 2024 and December 31, 2022,2023, respectively, with the remainder included in “Pension and other postretirement benefit obligations, net” in the condensed consolidated balance sheets).
Tredegar funds its other postretirement benefits on a claims-made basis; for 2023,2024, the Company anticipates the amount will be consistent with amounts paid for the year ended December 31, 2022,2023, or approximately $0.5$0.4 million.
5. OTHER INCOME (EXPENSE), NET
Other income (expense), net consists of the following: | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Gain on investment in kaléo(a) | $ | — | | | $ | 1,406 | | | $ | 262 | | | $ | 1,406 | |
COVID-19-related expenses, net of relief (b) | — | | | (96) | | | — | | | (308) | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other | (20) | | | 32 | | | (2) | | | (57) | |
Total | $ | (20) | | | $ | 1,342 | | | $ | 260 | | | $ | 1,041 | |
(a) In January 2023, additional cash consideration of $0.3 million was received related to the customary post-closing adjustments on the sale of the investment in kaleo, Inc ("kaléo"), which was sold in December 2021. (b) Costs associated with operating under COVID-19 conditions include employee overtime expenses associated with absenteeism, personal protective equipment supplies and facility maintenance. |
6. EARNINGS PER SHARE
Basic earnings per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed by dividing net income (loss) by the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows: | | | | Three Months Ended | | Six Months Ended |
| | June 30, | | June 30, |
(In thousands) | (In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
(In thousands) | |
(In thousands) | |
Weighted average shares outstanding used to compute basic earnings per share | |
Weighted average shares outstanding used to compute basic earnings per share | |
Weighted average shares outstanding used to compute basic earnings per share | Weighted average shares outstanding used to compute basic earnings per share | 34,079 | | | 33,814 | | | 33,988 | | | 33,734 | |
Incremental dilutive shares attributable to stock options and restricted stock | Incremental dilutive shares attributable to stock options and restricted stock | — | | | 40 | | | — | | | 42 | |
Incremental dilutive shares attributable to stock options and restricted stock | |
Incremental dilutive shares attributable to stock options and restricted stock | |
Shares used to compute diluted earnings per share | Shares used to compute diluted earnings per share | 34,079 | | | 33,854 | | | 33,988 | | | 33,776 | |
Shares used to compute diluted earnings per share | |
Shares used to compute diluted earnings per share | |
Incremental shares attributable to stock options and restricted stock are computed under the treasury stock method using the average market price during the related period. The Company had a net lossAverage out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 2,870,670 for the three and six months ended June 30, 2023, so there is no dilutive impact for such shares.March 31, 2024. If the Company had reported net income for the three and six months ended June 30,March 31, 2023, the average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock would have been 3,019,333 and 2,830,849, respectively. The average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 2,525,104 and 2,501,406 for the three and six months ended June 30, 2022, respectively.2,645,365.
6. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The changes in accumulated other comprehensive income (loss) by component for the three months ended June 30, 2023.March 31, 2024.
| | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) |
Balance at April 1, 2023 | $ | (84,959) | | | $ | (1,211) | | | $ | (56,749) | | | $ | (142,919) | |
Other comprehensive income (loss) | 1,800 | | | 2,488 | | | — | | | 4,288 | |
Income tax (expense) benefit | (179) | | | (945) | | | — | | | (1,124) | |
Other comprehensive income (loss), net of tax | 1,621 | | | 1,543 | | | — | | | 3,164 | |
Reclassification adjustment to net income (loss) | — | | | (1,621) | | | 2,923 | | | 1,302 | |
Income tax (expense) benefit | — | | | 446 | | | (637) | | | (191) | |
Reclassification adjustment to net income (loss), net of tax | — | | | (1,175) | | | 2,286 | | | 1,111 | |
Other comprehensive income (loss), net of tax | 1,621 | | | 368 | | | 2,286 | | | 4,275 | |
Balance at June 30, 2023 | $ | (83,338) | | | $ | (843) | | | $ | (54,463) | | | $ | (138,644) | |
The changes in accumulated other comprehensive income (loss) by component for the six months ended June 30, 2023.
| (In thousands) | (In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) | (In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) |
Balance at January 1, 2023 | $ | (86,079) | | | $ | (2,480) | | | $ | (59,036) | | | $ | (147,595) | |
Balance at January 1, 2024 | |
Other comprehensive income (loss) | Other comprehensive income (loss) | 3,356 | | | 5,565 | | | — | | | 8,921 | |
Income tax (expense) benefit | Income tax (expense) benefit | (615) | | | (2,031) | | | — | | | (2,646) | |
Other comprehensive income (loss), net of tax | Other comprehensive income (loss), net of tax | 2,741 | | | 3,534 | | | — | | | 6,275 | |
Reclassification adjustment to net income (loss) | Reclassification adjustment to net income (loss) | — | | | (2,594) | | | 5,847 | | | 3,253 | |
Income tax (expense) benefit | Income tax (expense) benefit | — | | | 697 | | | (1,274) | | | (577) | |
Reclassification adjustment to net income (loss), net of tax | Reclassification adjustment to net income (loss), net of tax | — | | | (1,897) | | | 4,573 | | | 2,676 | |
Other comprehensive income (loss), net of tax | Other comprehensive income (loss), net of tax | 2,741 | | | 1,637 | | | 4,573 | | | 8,951 | |
Balance at June 30, 2023 | $ | (83,338) | | | $ | (843) | | | $ | (54,463) | | | $ | (138,644) | |
Balance at March 31, 2024 | |
The changes in accumulated other comprehensive income (loss) by component for the three months ended June 30, 2022.March 31, 2023.
| | | | | | | | | | | | | | | | | | | | | | | |
(In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) |
Balance at April 1, 2022 | $ | (80,256) | | | $ | 6,831 | | | $ | (62,075) | | | $ | (135,500) | |
Other comprehensive income (loss) | (5,712) | | | (11,681) | | | — | | | (17,393) | |
Income tax (expense) benefit | 482 | | | 3,110 | | | — | | | 3,592 | |
Other comprehensive income (loss), net of tax | (5,230) | | | (8,571) | | | — | | | (13,801) | |
Reclassification adjustment to net income (loss) | — | | | (840) | | | 3,268 | | | 2,428 | |
Income tax (expense) benefit | — | | | 250 | | | (712) | | | (462) | |
Reclassification adjustment to net income (loss), net of tax | — | | | (590) | | | 2,556 | | | 1,966 | |
Other comprehensive income (loss), net of tax | (5,230) | | | (9,161) | | | 2,556 | | | (11,835) | |
Balance at June 30, 2022 | $ | (85,486) | | | $ | (2,330) | | | $ | (59,519) | | | $ | (147,335) | |
The changes in accumulated other comprehensive income (loss) by component for the six months ended June 30, 2022.
| (In thousands) | (In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) | (In thousands) | Foreign Currency Translation | | Gain (Loss) on Derivative Financial Instruments | | Pension & Other Postretirement Benefit Adjust | | Total Accumulated Other Comprehensive Income (Loss) |
Balance at January 1, 2022 | $ | (85,792) | | | $ | 901 | | | $ | (64,613) | | | $ | (149,504) | |
Balance at January 1, 2023 | |
Other comprehensive income (loss) | Other comprehensive income (loss) | 552 | | | (1,678) | | | — | | | (1,126) | |
Income tax (expense) benefit | Income tax (expense) benefit | (246) | | | (80) | | | — | | | (326) | |
Other comprehensive income (loss), net of tax | Other comprehensive income (loss), net of tax | 306 | | | (1,758) | | | — | | | (1,452) | |
Reclassification adjustment to net income (loss) | Reclassification adjustment to net income (loss) | — | | | (1,997) | | | 6,518 | | | 4,521 | |
Income tax (expense) benefit | Income tax (expense) benefit | — | | | 524 | | | (1,424) | | | (900) | |
Reclassification adjustment to net income (loss), net of tax | Reclassification adjustment to net income (loss), net of tax | — | | | (1,473) | | | 5,094 | | | 3,621 | |
Other comprehensive income (loss), net of tax | Other comprehensive income (loss), net of tax | 306 | | | (3,231) | | | 5,094 | | | 2,169 | |
Balance at June 30, 2022 | $ | (85,486) | | | $ | (2,330) | | | $ | (59,519) | | | $ | (147,335) | |
Balance at March 31, 2023 | |
The amounts reclassified out of accumulated other comprehensive income (loss) related to pension and other postretirement benefits is included in the computation of net periodic pension costs. See Note 4 for additional details.
8.7. DERIVATIVES
Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions and exposure from currency volatility that exists as part of ongoing business operations in Flexible Packaging Films. These derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the condensed consolidated balance sheet at fair value. If individual derivative instruments with the same counterparty can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.
In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certaina small subset of its customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the
scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments have durations generally no longer than 12 months. The notional amount of aluminum futures contracts that hedged future purchases of aluminum to meet fixed-price forward sales contract obligations was $17.0$6.8 million (11.1(5.1 million pounds of aluminum) at June 30, 2023March 31, 2024 and $30.7$7.7 million (20.3(5.6 million pounds of aluminum) at December 31, 2022.2023.
The table below summarizes the location and gross amounts of aluminum futures contract fair values (Level 2) in the condensed consolidated balance sheets as of June 30, 2023March 31, 2024 and December 31, 2022:2023: | | | June 30, 2023 | | December 31, 2022 | | March 31, 2024 | | December 31, 2023 |
(In thousands) | (In thousands) | Balance Sheet Account | | Fair Value | | Balance Sheet Account | | Fair Value | (In thousands) | Balance Sheet Account | | Fair Value | | Balance Sheet Account | | Fair Value |
Derivatives Designated as Hedging Instruments | Derivatives Designated as Hedging Instruments | |
| Asset derivatives: Aluminum futures contracts | Asset derivatives: Aluminum futures contracts | Prepaid expenses and other | | $ | — | | | Prepaid expenses and other | | $ | 48 | |
| Asset derivatives: Aluminum futures contracts | |
| Asset derivatives: Aluminum futures contracts | |
Liability derivatives: Aluminum futures contracts | Liability derivatives: Aluminum futures contracts | Accrued expenses | | (3,050) | | | Accrued expenses | | (3,260) | |
Aluminum futures contracts | Aluminum futures contracts | Other non-current liabilities | | (255) | | | Other non-current liabilities | | (369) | |
Net asset (liability) | Net asset (liability) | | $ | (3,305) | | | $ | (3,581) | |
In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related aluminum futures and/or forward contracts through the date of cancellation.
The Company's earnings are exposed to foreign currency exchange risk primarily through the translation of the financial statements of subsidiaries that have a functional currency other than the U.S. Dollar. The Company estimates that the net mismatch translation exposure for the Flexible Packaging Film's business unit in Brazil (“Terphane Ltda.”) of its sales and raw materials quoted or priced in U.S. Dollars and its variable conversion, fixed conversion and sales, general and administrative costs (before depreciation and amortization) quoted or priced in Brazilian Real ("R$") will result in an annual net cost of R$177139 million for the full year of 2023.2024.
Terphane Ltda. had the following outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars as of June 30, 2023:March 31, 2024: | | | | | | | | | | | | | | |
USD Notional Amount (000s) | Average Forward Rate Contracted on USD/BRL | R$ Equivalent Amount (000s) | Applicable Month | Estimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged |
| | | | |
| | | | |
| | | | |
$2,154 | 5.6378 | R$12,144 | Jul-23 | 83% |
$2,020 | 5.6831 | R$11,480 | Aug-23 | 78% |
$2,071 | 5.7174 | R$11,841 | Sep-23 | 80% |
$2,013 | 5.7556 | R$11,586 | Oct-23 | 79% |
$2,018 | 5.7836 | R$11,671 | Nov-23 | 79% |
$1,786 | 5.8312 | R$10,414 | Dec-23 | 71% |
$659 | 5.7360 | R$3,780 | Jan-24 | 23% |
$659 | 5.7562 | R$3,793 | Feb-24 | 23% |
$659 | 5.7774 | R$3,807 | Mar-24 | 23% |
$659 | 5.8000 | R$3,822 | Apr-24 | 23% |
$659 | 5.8207 | R$3,836 | May-24 | 24% |
$659 | 5.8419 | R$3,850 | Jun-24 | 24% |
$659 | 5.8636 | R$3,864 | Jul-24 | 24% |
$659 | 5.8872 | R$3,880 | Aug-24 | 24% |
$659 | 5.9118 | R$3,896 | Sep-24 | 24% |
$659 | 5.9350 | R$3,911 | Oct-24 | 24% |
$659 | 5.9581 | R$3,926 | Nov-24 | 24% |
$659 | 5.9813 | R$3,942 | Dec-24 | 24% |
$19,970 | 5.7808 | R$115,443 | | 40% |
| | | | | | | | | | | | | | |
USD Notional Amount (000s) | Average Forward Rate Contracted on USD/BRL | R$ Equivalent Amount (000s) | Applicable Month | Estimated % of Terphane Ltda. R$ Operating Cost Exposure Hedged |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
$1,827 | 5.3373 | R$9,751 | Apr-24 | 84% |
$1,798 | 5.3588 | R$9,635 | May-24 | 83% |
$1,812 | 5.3708 | R$9,732 | Jun-24 | 84% |
$1,804 | 5.3848 | R$9,714 | Jul-24 | 84% |
$1,806 | 5.4014 | R$9,755 | Aug-24 | 84% |
$1,857 | 5.4107 | R$10,048 | Sep-24 | 87% |
$1,851 | 5.4225 | R$10,037 | Oct-24 | 87% |
$1,837 | 5.4403 | R$9,994 | Nov-24 | 86% |
$1,801 | 5.4580 | R$9,830 | Dec-24 | 85% |
$16,393 | 5.3984 | R$88,496 | | 84% |
These foreign currency exchange contracts have been designated and qualify as cash flow hedges of Terphane Ltda.’s forecasted sales to customers quoted or priced in U.S. Dollars over that period. By changing the currency risk associated with these U.S. Dollar sales, the derivatives have the effect of offsetting operating costs quoted or priced in Brazilian Real and decreasing the net exposure to Brazilian Real in the condensed consolidated statements of income.
The table below summarizes the location and gross amounts of foreign currency forward contract fair values (Level 2) in the condensed consolidated balance sheets as of June 30, 2023March 31, 2024 and December 31, 2022:2023: | | | | | | | | | | | | | | | | | | | | | | | | |
| June 30, 2023 | | December 31, 2022 |
(In thousands) | Balance Sheet Account | | Fair Value | | Balance Sheet Account | | | Fair Value |
Derivatives Designated as Hedging Instruments | | | | | | | | |
Asset derivatives: Foreign currency forward contracts | Prepaid expenses and other | | $ | 2,974 | | | Prepaid expenses and other | | | $ | 781 | |
Foreign currency forward contracts | Other assets | | 723 | | | Other assets | | | 33 | |
Liability derivatives: Foreign currency forward contracts | Accrued expenses | | — | | | Other non-current liabilities | | | (3) | |
Net asset (liability) | | | $ | 3,697 | | | | | | $ | 811 | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2024 | | December 31, 2023 |
(In thousands) | Balance Sheet Account | | Fair Value | | Balance Sheet Account | | | Fair Value |
Derivatives Designated as Hedging Instruments | | | | | | | | |
Asset derivatives: Foreign currency forward contracts | Prepaid expenses and other | | $ | 1,154 | | | Prepaid expenses and other | | | $ | 2,050 | |
Foreign currency forward contracts | Other assets | | — | | | Other assets | | | 146 | |
Liability derivatives: Foreign currency forward contracts | Accrued expenses | | (6) | | | Other non-current liabilities | | | — | |
Foreign currency forward contracts | Other non-current liabilities | | (2) | | | Other non-current liabilities | | | — | |
Net asset (liability) | | | $ | 1,146 | | | | | | $ | 2,196 | |
These derivative contracts involve elements of market risk that are not reflected on the condensed consolidated balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to any forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most credit-worthy customers. The counterparties to the Company’s foreign currency cash flow hedge contracts are major financial institutions.
The pre-tax effect on net income (loss) and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for the three and six month periods ended June 30,March 31, 2024 and 2023 and 2022 is summarized in the table below: | | Cash Flow Derivative Hedges |
| Cash Flow Derivative Hedges | | | Cash Flow Derivative Hedges |
| | Three Months Ended June 30, | | Three Months Ended March 31, |
| | Aluminum Futures Contracts | | Foreign Currency Forwards | | Aluminum Futures Contracts | | Foreign Currency Forwards |
(In thousands) | (In thousands) | 2023 | | 2022 | | 2023 | | 2022 | (In thousands) | 2024 | | 2023 | | 2024 | | 2023 |
Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | $ | 557 | | | $ | (9,923) | | | $ | — | | $ | 1,931 | | | $ | — | | | $ | (1,758) | |
Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold | | Cost of goods sold | | Cost of goods sold | Selling, general & admin | | Cost of goods sold | | Selling, general & admin | Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold | | Cost of goods sold | | Cost of goods sold | Selling, general & admin | | Cost of goods sold | | Selling, general & admin |
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | $ | 885 | | | $ | 293 | | | $ | 15 | | $ | 721 | | | $ | 15 | | | $ | 532 | |
| | Six Months Ended June 30, |
| | Aluminum Futures Contracts | | Foreign Currency Forwards |
| | 2023 | | 2022 | | 2023 | | 2022 |
Amount of pre-tax gain (loss) recognized in other comprehensive income (loss) | $ | 1,959 | | | $ | (3,741) | | | $ | — | | $ | 3,606 | | | $ | — | | | $ | 2,063 | |
Location of gain (loss) reclassified from accumulated other comprehensive income (loss) into net income (effective portion) | Cost of goods sold | | Cost of goods sold | | Cost of goods sold | Selling, general & admin | | Cost of goods sold | | Selling, general & admin |
Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) to net income (effective portion) | $ | 1,557 | | | $ | 1,298 | | | $ | 30 | | $ | 1,007 | | | $ | 30 | | | $ | 669 | |
|
As of June 30, 2023,March 31, 2024, the Company expects $1.8$0.4 million of unrealized after-tax lossesgains on aluminum and foreign currency derivative instruments reported in accumulated other comprehensive income (loss) to be reclassified to earnings within the next 12 months. For the three and six month periods ended June 30,March 31, 2024 and 2023, and 2022, net gains or losses realized, from previously unrealized net gains or losses on hedges that had been discontinued, were not material.
9.8. INCOME TAXES
Tredegar recorded tax benefitexpense (benefit) of $3.0$0.7 million on pre-tax lossincome (loss) of $22.9$3.9 million in the first sixthree months of 2023. Therefore, the2024. The effective tax rate in the first sixthree months of 20232024 was 13.1%, compared to 16.9%16.7% and (48.8)% in the first sixthree months of 2022.2023. The change in the effective tax rate iswas primarily due to a pre-tax loss in first six months of 2023 versus pre-tax income in first six months of 2022, lower Brazil tax incentives, a discrete charge in the second quarter of 2023 for a Brazil tax law change and a large discrete benefit recorded in the first quarter of 2022, resulting2024 versus a pre-tax loss in the first three months of 2023.
The effective tax rate for the first three months of 2024 varies from the implementation21% statutory rate primarily due to foreign rate differences and non-deductible expenses offset by Brazilian tax incentives and federal tax credits. Brazil income tax was deemed deductible but not creditable in the U.S. in the first three months of new U.S. tax regulations associated with foreign tax credits published2023. As a result of guidance released by the U.S. Treasury and Internal Revenue Service on("IRS") in the fourth quarter of 2023, and new Brazil tax legislation effective January 4, 2022. These regulations overhauled various components of the foreign tax credit regime including the determination of creditable foreign taxes and limit the amount of foreign taxes that are creditable against U.S. income taxes. As the result of these regulations, future Brazilian1, 2024, Brazil income tax under Brazil tax law in place at that time would have been deductible, but notis deemed creditable in the U.S. The accounting rules require a reduction of the U.S. deferred tax liability previously established related to anticipated future income from Brazil. The tax effect of the reduction of the U.S. deferred tax liability resulted in the discrete tax benefit described above. In the second quarter of 2023, Brazil enacted new tax legislation which will likely cause the Brazil income tax to once again be creditable after 2023. This law change caused a partial reversal of the discrete tax benefit recognized in the first quarter of 2022 described above, which increased the deferred tax liability related to anticipated future income from Brazil. Total deferred tax assets increased during the second quarter of 2023 compared to December 31, 2022 primarily due to changes in other comprehensive income, increase in net operational loss and decrease in deferred tax liability related to the goodwill impairment that took place in second quarter of 2023.for 2024.
Tredegar accrues U.S. federal income taxes on unremitted earnings of foreign subsidiaries where required. However, due to changes in the taxation of dividends under the U.S. Tax Cuts and Jobs Act of 2017, Tredegar will only record U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries.
The Brazilian federal statutory income tax rate is a composite of 34.0% (25.0% of income tax and 9.0% of social contribution on income). Terphane Ltda.’s manufacturing facility in Brazil is the beneficiary of certain income tax incentives that allow for a reduction in the statutory Brazilian federal income tax rate to 15.25% levied on the operating profit on certain of its products. The incentives have been granted for a 10-year period, from the commencement date of January 1, 2015 and expiring at the end of 2024. The benefit from the tax incentives was $0.4 million and $2.6 million in the first six months of 2023 and 2022, respectively.
Tredegar and its subsidiaries file income tax returns in the U.S., various states, and jurisdictions outside the U.S. With exceptions for some U.S. states and non-U.S. jurisdictions, Tredegar and its subsidiaries as of June 30, 2023 are no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2018.
10.9. BUSINESS SEGMENTS
The Company’s business segments are Aluminum Extrusions, PE Films, and Flexible Packaging Films. Information by business segment is reported below. There are no accounting transactions between segments and no allocations to segments.
The Company’s reportable segments are based on its method of internal reporting, which is generally segregated by differences in products. Accounting standards for presentation of segments require an approach based on the way the Company organizes the segments for making operating decisions and how the chief operating decision maker (“CODM”)CODM assesses performance. EBITDAEarnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations is the key profitability measure used by the CODM (Tredegar’s President and Chief Executive Officer) for purposes of assessing financial performance. The Company uses sales less freight (“net sales”) as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
The following table presents net sales and EBITDA from ongoing operations by segment for the three and six months ended June 30, 2023March 31, 2024 and 2022:
| | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended June 30, | | Six Months Ended June 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Net Sales | | | | | | | |
Aluminum Extrusions | $ | 121,827 | | | $ | 190,308 | | | $ | 255,197 | | | $ | 348,417 | |
PE Films | 15,918 | | | 31,424 | | | 36,099 | | | 62,555 | |
Flexible Packaging Films | 33,223 | | | 41,595 | | | 64,750 | | | 80,839 | |
Total net sales | 170,968 | | | 263,327 | | | 356,046 | | | 491,811 | |
Add back freight | 7,199 | | | 11,036 | | | 13,243 | | | 19,118 | |
Sales as shown in the condensed consolidated statements of income (loss) | $ | 178,167 | | | $ | 274,363 | | | $ | 369,289 | | | $ | 510,929 | |
EBITDA from Ongoing Operations | | | | | | | |
Aluminum Extrusions: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | $ | 10,217 | | | $ | 21,895 | | | $ | 24,855 | | | $ | 45,814 | |
Depreciation & amortization | (4,158) | | | (4,169) | | | (8,569) | | | (8,430) | |
EBIT | 6,059 | | | 17,726 | | | 16,286 | | | 37,384 | |
Plant shutdowns, asset impairments, restructurings and other | 155 | | | 16 | | | (339) | | | (89) | |
PE Films: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | 814 | | | 7,065 | | | 2,663 | | | 14,112 | |
Depreciation & amortization | (1,552) | | | (1,559) | | | (3,195) | | | (3,154) | |
EBIT | (738) | | | 5,506 | | | (532) | | | 10,958 | |
Plant shutdowns, asset impairments, restructurings and other | — | | | (50) | | | 2 | | | (153) | |
Goodwill impairment | (15,413) | | | — | | | (15,413) | | | — | |
Flexible Packaging Films: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | 249 | | | 7,631 | | | 1,599 | | | 12,665 | |
Depreciation & amortization | (711) | | | (583) | | | (1,411) | | | (1,132) | |
EBIT | (462) | | | 7,048 | | | 188 | | | 11,533 | |
Plant shutdowns, asset impairments, restructurings and other | (1) | | | (37) | | | (79) | | | (80) | |
Total | (10,400) | | | 30,209 | | | 113 | | | 59,553 | |
Interest income | 30 | | | 3 | | | 74 | | | 32 | |
Interest expense | 2,374 | | | 1,234 | | | 4,686 | | | 2,020 | |
Gain on investment in kaléo | — | | | 1,406 | | | 262 | | | 1,406 | |
Stock option-based compensation costs | — | | | 251 | | | 231 | | | 882 | |
Corporate expenses, net | 9,509 | | | 9,708 | | | 18,466 | | | 20,463 | |
Income (loss) before income taxes | (22,253) | | | 20,425 | | | (22,934) | | | 37,626 | |
Income tax expense (benefit) | (3,331) | | | 5,556 | | | (3,000) | | | 6,334 | |
Net income (loss) | $ | (18,922) | | | $ | 14,869 | | | $ | (19,934) | | | $ | 31,292 | |
2023:
| | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | |
(In thousands) | 2024 | | 2023 | | | | |
Net Sales | | | | | | | |
Aluminum Extrusions | $ | 114,222 | | | $ | 133,370 | | | | | |
PE Films | 24,735 | | | 20,182 | | | | | |
Flexible Packaging Films | 30,113 | | | 31,527 | | | | | |
Total net sales | 169,070 | | | 185,079 | | | | | |
Add back freight | 6,666 | | | 6,043 | | | | | |
Sales as shown in the condensed consolidated statements of income (loss) | $ | 175,736 | | | $ | 191,122 | | | | | |
EBITDA from Ongoing Operations | | | | | | | |
Aluminum Extrusions: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | $ | 12,540 | | | $ | 14,638 | | | | | |
Depreciation & amortization | (4,542) | | | (4,411) | | | | | |
EBIT | 7,998 | | | 10,227 | | | | | |
Plant shutdowns, asset impairments, restructurings and other | (1,167) | | | (493) | | | | | |
PE Films: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | 6,904 | | | 1,849 | | | | | |
Depreciation & amortization | (1,329) | | | (1,643) | | | | | |
EBIT | 5,575 | | | 206 | | | | | |
Plant shutdowns, asset impairments, restructurings and other | (504) | | | 2 | | | | | |
| | | | | | | |
Flexible Packaging Films: | | | | | | | |
Ongoing operations: | | | | | | | |
EBITDA | 1,963 | | | 1,350 | | | | | |
Depreciation & amortization | (751) | | | (700) | | | | | |
EBIT | 1,212 | | | 650 | | | | | |
Plant shutdowns, asset impairments, restructurings and other | — | | | (78) | | | | | |
Total | 13,114 | | | 10,514 | | | | | |
Interest income | 22 | | | 44 | | | | | |
Interest expense | 3,455 | | | 2,311 | | | | | |
Gain on investment in kaleo, Inc. | — | | | 262 | | | | | |
Stock option-based compensation costs | — | | | 231 | | | | | |
| | | | | | | |
Corporate expenses, net | 5,736 | | | 8,956 | | | | | |
Income (loss) before income taxes | 3,945 | | | (678) | | | | | |
Income tax expense (benefit) | 657 | | | 331 | | | | | |
Net income (loss) | $ | 3,288 | | | $ | (1,009) | | | | | |
The following table presents identifiable assets by segment at June 30, 2023March 31, 2024 and December 31, 2022:2023: | (In thousands) | (In thousands) | June 30, 2023 | | December 31, 2022 | (In thousands) | March 31, 2024 | | December 31, 2023 |
Aluminum Extrusions | Aluminum Extrusions | $ | 266,426 | | | $ | 293,308 | |
PE Films | PE Films | 82,191 | | | 102,431 | |
Flexible Packaging Films | Flexible Packaging Films | 91,568 | | | 103,448 | |
Subtotal | Subtotal | 440,185 | | | 499,187 | |
General corporate | General corporate | 23,491 | | | 23,674 | |
Cash and cash equivalents | 21,193 | | | 19,232 | |
Cash, cash equivalents and restricted cash | |
Total | Total | $ | 484,869 | | | $ | 542,093 | |
The following tables disaggregate the Company’s revenue by geographic area and product group for the three and six months ended June 30, 2023March 31, 2024 and 2022:2023: | Net Sales by Geographic Area (a) | | Three Months Ended June 30, | | Six Months Ended June 30, |
Net Sales by Geographic Area (a) | |
Net Sales by Geographic Area (a) | |
| Three Months Ended March 31, | |
(In thousands) | |
(In thousands) | |
(In thousands) | (In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
United States | United States | $ | 133,417 | | | $ | 213,955 | | | $ | 284,027 | | | $ | 396,092 | |
United States | |
United States | |
Exports from the United States to: | |
Exports from the United States to: | |
Exports from the United States to: | Exports from the United States to: | |
Asia | Asia | 5,477 | | | 14,680 | | | 11,209 | | | 27,145 | |
Asia | |
Asia | |
Latin America | |
Latin America | |
Latin America | Latin America | 1,817 | | | 1,245 | | | 3,676 | | | 2,686 | |
Canada | Canada | 4,955 | | | 4,173 | | | 9,239 | | | 8,366 | |
Canada | |
Canada | |
Europe | |
Europe | |
Europe | Europe | 272 | | | 1,085 | | | 1,132 | | | 2,448 | |
Operations outside the United States: | Operations outside the United States: | |
Operations outside the United States: | |
Operations outside the United States: | |
Brazil | |
Brazil | |
Brazil | Brazil | 24,975 | | | 28,189 | | | 46,603 | | | 55,074 | |
Asia | Asia | 55 | | | — | | | 160 | | | — | |
Asia | |
Asia | |
Total | |
Total | |
Total | Total | $ | 170,968 | | | $ | 263,327 | | | $ | 356,046 | | | $ | 491,811 | |
(a) Export sales relate mostly to PE Films. Operations in Brazil relate to Flexible Packaging Films. | (a) Export sales relate mostly to PE Films. Operations in Brazil relate to Flexible Packaging Films. | |
(a) Export sales relate mostly to PE Films. Operations in Brazil relate to Flexible Packaging Films. | |
The Company’s facilities in Pottsville, PA (“PV”) and Guangzhou, China (“GZ”) have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market, but paid by customers directly to PV. Amounts associated with this intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of $3.4$6.1 million and $5.3 million in the second quarter of 2023 and 2022, respectively, and $6.8 million and $11.7$3.4 million in the first six monthsquarter of 20232024 and 2022,2023, respectively.
| | | | | | | | | | | | | | | |
Net Sales by Product Group |
| Three Months Ended March 31, | | |
(In thousands) | 2024 | | 2023 | | | | |
Aluminum Extrusions: | | | | | | | |
Nonresidential building & construction | $ | 66,347 | | | $ | 78,629 | | | | | |
Consumer durables | 7,984 | | | 10,347 | | | | | |
Automotive | 10,606 | | | 12,122 | | | | | |
Residential building & construction | 7,902 | | | 11,603 | | | | | |
Electrical | 5,836 | | | 8,129 | | | | | |
Machinery & equipment | 12,195 | | | 10,724 | | | | | |
Distribution | 3,352 | | | 1,816 | | | | | |
Subtotal | 114,222 | | | 133,370 | | | | | |
PE Films: | | | | | | | |
Surface protection films | 17,011 | | | 12,855 | | | | | |
Overwrap packaging | 7,724 | | | 7,327 | | | | | |
Subtotal | 24,735 | | | 20,182 | | | | | |
Flexible Packaging Films | 30,113 | | | 31,527 | | | | | |
Total | $ | 169,070 | | | $ | 185,079 | | | | | |
10. DEBT
ABL Facility
On December 27, 2023, the Company entered into Amendment No. 3 (the “ABL Facility”) to the Second Amended and Restated Credit Agreement, which provides the Company with a $180 million senior secured asset-based revolving credit facility that will expire on June 30, 2026. On April 16, 2024, the Company entered into Amendment No. 4 (the "Amendment") that, among other items: (i) moves the ABL Adjustment Date (defined below) from March 31, 2025 to September 30, 2025 and (ii) requires weekly reporting of the borrowing base financial covenant. The ABL Facility is secured by substantially all assets of the Company and its domestic subsidiaries, including equity in certain material first-tier foreign subsidiaries. Availability for
| | | | | | | | | | | | | | | | | | | | | | | |
Net Sales by Product Group |
| Three Months Ended June 30, | | Six Months Ended June 30, |
(In thousands) | 2023 | | 2022 | | 2023 | | 2022 |
Aluminum Extrusions: | | | | | | | |
Nonresidential building & construction | $ | 65,784 | | | $ | 99,302 | | | $ | 144,413 | | | $ | 180,223 | |
Consumer durables | 11,714 | | | 18,805 | | | 22,061 | | | 35,695 | |
Automotive | 11,769 | | | 14,473 | | | 23,891 | | | 28,314 | |
Residential building & construction | 10,056 | | | 20,948 | | | 21,659 | | | 37,413 | |
Electrical | 6,078 | | | 9,687 | | | 14,207 | | | 16,974 | |
Machinery & equipment | 11,082 | | | 15,929 | | | 21,806 | | | 28,874 | |
Distribution | 5,344 | | | 11,164 | | | 7,160 | | | 20,924 | |
Subtotal | 121,827 | | | 190,308 | | | 255,197 | | | 348,417 | |
PE Films: | | | | | | | |
Surface protection films | 8,643 | | | 23,674 | | | 21,497 | | | 45,822 | |
Overwrap packaging | 7,275 | | | 7,750 | | | 14,602 | | | 16,733 | |
Subtotal | 15,918 | | | 31,424 | | | 36,099 | | | 62,555 | |
Flexible Packaging Films | 33,223 | | | 41,595 | | | 64,750 | | | 80,839 | |
Total | $ | 170,968 | | | $ | 263,327 | | | $ | 356,046 | | | $ | 491,811 | |
borrowings under the ABL Facility is governed by a borrowing base, determined by the application of specified advance rates against eligible assets, including a portion of trade accounts receivable, inventory, cash and cash equivalents, owned real properties, and owned machinery and equipment. Upon the earlier of September 30, 2025 or the date the Company receives the proceeds from the sale of Terphane (the “ABL Adjustment Date”), the $180 million ABL Facility will be reduced to $125 million. As of March 31, 2024, availability under the ABL Facility was $22.2 million, after reducing the borrowing base by the aggregate outstanding borrowings of $128.3 million, standby letters of credit of $13.1 million, and the Minimum Liquidity (as defined in the ABL Facility) financial covenant.Outstanding borrowings accrue interest at the rates elected by the Company depending on the type of loan and denomination of such borrowing. With respect to revolving loans denominated in U.S. Dollars, the Company may elect interest rates at:
•Alternate Base Rate (“ABR”) plus 2.50% before the ABL Adjustment Date and the applicable ABR Spread (as defined in the ABL Facility) after the ABL Adjustment Date are determined in accordance with an excess availability-based pricing grid. ABR is defined, in part, as the greater of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day plus ½ of 1% and (c) the Adjusted Term SOFR Rate (defined below) for a one-month period plus 1%; or
•The Adjusted Term Secured Overnight Financing Rate ("SOFR") Rate plus 3.50% before the ABL Adjustment Date and the applicable Term Benchmark Spread (as defined in the ABL Facility) are determined in accordance with an excess availability-based pricing grid after the ABL Adjustment Date. Adjusted Term SOFR Rate is defined as the Term SOFR Rate plus 0.10%, subject to an initial Floor (as defined in the ABL Facility) of 0%.
11. SUPPLY CHAIN FINANCINGInterest rate indices for select non-U.S. dollar borrowings, including borrowings denominated in Euro, Pounds Sterling, Swiss Francs and Japanese Yen, remain consistent with the Second Amended and Restated Credit Agreement.
Based upon the quarterly average of daily availability under the ABL Facility, the interest rate pricing grid applicable after the ABL Adjustment Date will be as follows: | | | | | | | | | | | |
Pricing under the ABL Facility (Basis Points) |
Quarter Average of Daily Availability | Term Benchmark Spread | ABR Spread | Commitment Fee* |
> 66% of $125 million aggregate commitment | 225.0 | 125.0 | 40.0 |
≤ 66% but > 33% of $125 million aggregate commitment | 250.0 | 150.0 | 40.0 |
≤ 33% of $125 million aggregate commitment | 275.0 | 175.0 | 40.0 |
*The Commitment Fee before the ABL Adjustment Date and after the ABL Adjustment Date remain the same as reflected in this table. |
Under the terms of the ABL Facility, certain domestic bank accounts are subject to blocked account agreements, each of which contains a springing feature whereby the lenders may exercise control over those accounts during a cash dominion period (any such period, a “Cash Dominion Period”). A Cash Dominion Period was implemented on the date of the closing of the ABL Facility and will remain in effect at all times prior to the ABL Adjustment Date. After the ABL Adjustment Date, a Cash Dominion Period goes into effect if availability under the ABL Facility falls below 12.5% or an Event of Default (as defined in the ABL Facility) occurs. The Company would then be subject to the Cash Dominion Period until the Event of Default is waived or ABL Facility availability is above 12.5% of the $125 million aggregate commitment for 30 consecutive days. Receipts that have not yet been applied to the ABL Facility are classified as restricted cash in the Company’s consolidated balance sheets.
The Company has supply chain finance service agreements with third-party financial institutions to provide platforms that facilitatecovenants in the ability of participating suppliers to finance payment obligations fromABL Facility are as follows:
•Until the ABL Adjustment Date, the Company withis required to maintain (i) a minimum Credit EBITDA (as defined in the third-party financial institution. The Company’s obligations to its suppliers, including amounts due and scheduled payment dates, are not affected by suppliers’ decisions to finance amounts under the supply chain finance agreements. As of June 30, 2023 and December 31, 2022, $14.6 million and $25.9 million, respectively,ABL Facility), as of the Company’s accounts payable were financed by participating suppliers through third-party financial institutions.
end of each fiscal month for the 12-month period then ended (presented below) and (ii) a Minimum Liquidity (as defined in the ABL Facility) of $10.0 million.
12. SUBSEQUENT EVENTS | | | | | |
Minimum Credit EBITDA (In thousands) |
March 2024 | $ | 16,640 | |
April 2024 | 19,780 | |
May 2024 | 19,660 | |
June 2024 | 19,450 | |
July 2024 | 21,860 | |
August 2024 | 22,830 | |
September 2024 | 25,370 | |
October 2024 | 26,070 | |
November 2024 | 27,640 | |
December 2024 | 29,640 | |
January 2025 | 29,740 | |
February 2025 | 29,850 | |
March 2025 | 29,980 | |
April 2025 | 30,340 | |
May 2025 | 30,700 | |
June 2025 | 31,030 | |
July 2025 | 31,370 | |
August 2025 | 31,710 | |
September 2025 | $ | 32,080 | |
Closure•Following the ABL Adjustment Date, the foregoing financial covenants will cease to exist and will be replaced with a minimum fixed charge coverage ratio of PE Films Technical Center1.00:1.00 that will be triggered in the event that availability is less than 10% of $125 million commitment amount and continuing thereafter until availability is greater than 10% of the $125 million commitment amount for 30 consecutive days.
In addition to the financial covenants, the ABL Facility contains restrictive covenants, including covenants that restrict the Company’s ability to pay dividends and repurchase shares of its common stock.
If at any time the availability under the ABL facility after the ABL Adjustment Date is less than 20% of the maximum aggregate principal amount in effect at such time or an Event of Default occurs, the Company’s current weekly reporting requirements to lenders will continue until the Event of Default is waived, cured or the availability under the ABL facility is above 20% of the maximum aggregate principal amount for 30 consecutive days.
The ABL Facility has customary representations and warranties including, as a condition to each borrowing, that all such representations and warranties are true and correct in all material respects (including a representation that no Material Adverse Effect (as defined in the ABL Facility) has occurred since December 31, 2022). In the event that the Company cannot certify that all conditions to the borrowing have been met, the lenders can restrict the Company’s future borrowings under the ABL Facility. Because a Cash Dominion Period is currently in effect and the Company is required to represent that no Material Adverse Effect has occurred as a condition to borrowing, the outstanding debt under the ABL Facility (all contractual payments due on June 30, 2026) is classified as a current liability in the condensed consolidated balance sheets.
In accordance with the ABL Facility, the lenders have been provided with the Company’s financial statements, covenant compliance certificates and projections to facilitate their ongoing assessment of the Company. Accordingly, the Company believes the likelihood that lenders would exercise the subjective acceleration clause whereby prohibiting future borrowings is remote. As of March 31, 2024, the Company was in compliance with all debt covenants.
Terphane Brazil Loan
On AugustOctober 26, 2023, Flexible Packaging Film's business unit in Brazil (“Terphane Ltda.”), the Company’s wholly owned subsidiary in Brazil, borrowed $20 million secured by certain of its assets (“Terphane Brazil Loan”). This U.S. Dollar borrowing matures on October 30, 2028, with interest payable quarterly at an annual floating interest rate of the SOFR plus 5.99%. The SOFR rate was 5.31% as of March 31, 2024. Quarterly principal payments of $1.7 million begin starting in year 3 of the loan. There are no prepayment penalties. The Company expects that the Terphane Brazil Loan will be repaid (and collateral released) upon the closing of the Contingent Terphane Sale. On October 26, 2023, the Company adopted a plan to close the PE Films technical center in Richmond, VA and reduce its efforts to develop and sell films supporting the semiconductor market. Future research & development activities for PE Films will be performedborrowed $20 million from Terphane Ltda. (the “Intercompany Loan”) at the facility in Pottsville, PA. PE Films continuessame interest rate as the Terphane Brazil Loan, thereby transferring the funds to have new business opportunities primarily relating to surface protection films that protect components of flat panel and flexible displays.the U.S. The Company anticipates all activities to cease atwill repay the PE Films technical centerIntercompany Loan in Richmond, VA, byconjunction with the end of 2023. The Company expects to recognize cash costs associated with exit activities of $1.8 million for: (i) severance and related costs ($0.9 million), (ii) vacating the facility lease ($0.6 million payable through June 2025), and (iii) building closure costs ($0.3 million). In addition, the Company expects non-cash asset write-offs and accelerated depreciation of up to $4.5 million. Net annual cash savings of $3.4 million are anticipated, beginning in the fourth quarter of 2023.
Entry into an Amendment to the Credit Agreement and Suspension of Regular Quarterly Dividend
Subsequent to June 30, 2023, to reduce the risk of potential violationsclosing of the primary financial restrictive covenants in its five-year, revolving, secured credit facility that matures on June 29, 2027 (the "Credit Agreement"), the Company (i) suspended its regular quarterly dividend (which had an annual cash outlay of approximately $17.7 million) and (ii) amended the Credit Agreement, effective August 3, 2023, to:
a.Change the fiscal quarter maximum Total Net Leverage Ratio covenant from 4.0x to: (i) 5.0x for the quarters ending September 30, 2023 through March 31, 2024, (ii) 4.75x for the quarter ending June 30, 2024, (iii) 4.25 for the quarter ending September 30, 2024, and (iv) 4.0x for the quarter ending December 31, 2024 and thereafter.
b.Change the fiscal quarter minimum Interest Coverage Ratio covenant from 3.0x to: (i) 2.50x for the quarters ending September 30, 2023 through June 30, 2024, (ii) 2.75x for the quarter ending September 30, 2024, and (iii) 3.0x for the quarter ending December 31, 2024 and thereafter.
c.Reduce the maximum borrowing availability from $375 million to $200 million.
d.Increase the drawn spread by 25 basis points across all levels of the interest rate pricing grid, beginning the quarter ending September 30, 2023.
e.Amend the restricted payments covenant to prohibit dividends and share repurchases during fiscal quarters ending September 30, 2023 through December 31, 2024.
Contingent Terphane Sale.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Forward-looking and Cautionary Statements
Some of the information contained in this Quarterly Report on Form 10-Q ("Form 10-Q") may constitute “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words “believe,” “estimate,” “anticipate,” “appear to,” “expect,” “project,” “plan,” “likely,” “may” and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. Factors that could cause actual results to differ materially from expectations include, without limitation, the following:
•inability to successfully complete strategic dispositions, including the Contingent Terphane Sale, failure to realize the expected benefits of such dispositions and assumption of unanticipated risks in such dispositions;
•inability to successfully transition into an asset-based revolving lending facility;
•noncompliance with any of the financial and other restrictive covenants in the Company's asset-based credit facility;
•the impact of macroeconomic factors, such as inflation, interest rates, recession risks and other lagging effects of the COVID-19 pandemic
•an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;
•failure to continue to attract, develop and retain certain key officers or employees;
•disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
•inability to develop, efficiently manufacture and deliver new products at competitive prices;
•the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by Bonnell Aluminum;
•failure to prevent foreign companies from evading anti-dumping and countervailing duties;
•unanticipated problems or delays with the implementation of the enterprise resource planning and manufacturing executions systems, or security breaches and other disruptions to the Company's information technology infrastructure;
•loss or gain of sales to significant customers on which the Company’s business is highly dependent;
•inability to achieve sales to new customers to replace lost business;
•inability to develop, efficiently manufacture and deliver new products at competitive prices;
•failure of the Company’s customers to achieve success or maintain market share;
•failure to protect our intellectual property rights;
•risks of doing business in countries outside the U.S. that affect our international operations;
•political, economic and regulatory factors concerning the Company’s products;
•uncertain economic conditions in countries in which the Company does business, including continued high inflation and the effects of the Russian invasion of Ukraine;
•competition from other manufacturers, including manufacturers in lower-cost countries and manufacturers benefiting from government subsidies;
•impact of fluctuations in foreign exchange rates;
•movementthe termination of pension plan assets and liabilities relatinganti-dumping duties on products imported to differences between the ultimate settlement benefit obligation and the projected benefit obligation, census data, administrative costs, and the effectiveness of hedging activities;Brazil that compete with products produced by Flexible Packaging;
•an increase in the operating costs incurred by the Company’s business units, including, for example, the cost of raw materials and energy;information technology system failure or breach;
•unanticipated problems or delays with the implementationimpact of an enterprise resource planningpublic health epidemics on employees, production and manufacturing executions systems, or security breaches and other disruptions to the Company's information technology infrastructure;global economy, such as the COVID-19 pandemic;
•inability to successfully identify, complete or integrate strategic acquisitions; failure to realize the expected benefits of such acquisitions and assumption of unanticipated risks in such acquisitions;
•disruptions to the Company’s manufacturing facilities, including those resulting from labor shortages;
•failure to continue to attract, develop and retain certain key officers or employees;
•noncompliance with any of the financial and other restrictive covenants in the Company's revolving credit facility;
•the impact of public health epidemics on employees, production and the global economy, such as the COVID-19 pandemic;
•an information technology system failure or breach;
•the impact of the imposition of tariffs and sanctions on imported aluminum ingot used by Bonnell Aluminum;
•the impact of new tariffs, duties or other trade restrictions imposed as a result of trade tensions between the U.S. and other countries;
•the termination of anti-dumping duties on products imported to Brazil that compete with products produced by Flexible Packaging;
•impairment of the Surface Protection reporting unit's goodwill;
•failure to establish and maintain effective internal control over financial reporting;
and the other factors discussed in the reports Tredegar files with or furnishes to the Securities and Exchange Commission (the “SEC”) from time to time, including the risks and important factors set forth in additional detail in Part I, Item 1A of Tredegar’s
Annual Report on Form 10-K for the year ended December 31, 20222023 (the “2022“2023 Form 10-K”) and Part II, Item 1A of this Form 10-Q.. Readers are urged to review and consider carefully the disclosures Tredegar makes in its filings with the SEC.
Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management’s expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.
References herein to “Tredegar,” “the Company,” “we,” “us” and “our” are to Tredegar Corporation and its subsidiaries, collectively, unless the context otherwise indicates or requires.
Unless otherwise stated or indicated, all comparisons are to the prior year period. References to "Notes" are to notes to our condensed consolidated financial statements found in Part I, Item 1 of this Form 10-Q.
Critical Accounting Policies and Estimates
In the ordinary course of business, the Company makes a number of estimates and assumptions relating to the reporting of results of operations and financial position in the preparation of financial statements in conformity with generally accepted accounting standards in the United States ("GAAP"). The Company believes the estimates, assumptions and judgments described in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates” in the 20222023 Form 10-K have the greatest potential impact on our financial statements, so Tredegar considers these to be its critical accounting policies. Since December 31, 2022,2023, there have been no changes in these policies or estimates that have had a material impact on our results of operations or financial position.
Business Overview
Tredegar Corporation is an industrial manufacturer with three primary businesses: custom aluminum extrusions for the North American building and construction ("B&C"), automotive and specialty end-use markets through its Aluminum Extrusions segment; surface protection films for high-technology applications in the global electronics industry through its PE Films segment; and specialized polyester films primarily for the Latin American flexible packaging market through its Flexible Packaging Films segment. With approximately 1,8001,900 employees, the Company operates manufacturing facilities in North America, South America, and Asia.
Earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations is the measure of segment profit and loss used by Tredegar’s chief operating decision maker ("CODM") for purposes of assessing financial performance. The Company uses sales less freight (“net sales”) as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
Earnings before interest and taxes ("EBIT") from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company in Note 10.9. It is not intended to represent the stand-alone results for Tredegar's ongoing operations under GAAP and should not be considered as an alternative to net income as defined by GAAP. We believe that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management’s performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company’s core operations.
SecondFirst quarter 20232024 net income (loss) was $(18.9)$3.3 million ($(0.56)0.10 per diluted share) compared with net income (loss) of $14.9$(1.0) million ($0.44(0.03) per diluted share) in the secondfirst quarter of 2022.2023.
SecondFirst Quarter Financial Results Highlights
•EBITDA from ongoing operations for Aluminum Extrusions was $10.2$12.5 million in the secondfirst quarter of 20232024 versus $21.9$14.6 million in the secondfirst quarter of last year. EBITDA from ongoing operations duringyear and $8.0 million in the last four quarters has been weak, in a rangefourth quarter of $8.9 to $14.6 million.2023.
◦Sales volume of 35.5was 33.8 million pounds in the secondfirst quarter of 2023 was relatively consistent with2024 versus 37.6 million pounds in the first quarter of 2023last year and 32.9 million pounds in the fourth quarter of 2022 but declined significantly versus 49.0 million pounds in the second quarter of last year.2023.
◦Open orders at the end of the secondfirst quarter of 2024 were approximately 15 million pounds (versus 27 million pounds in the first quarter of 2023 were 20 million pounds (versus 27and 14 million pounds at the end of the firstfourth quarter of 2023), which is below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions that resulted in excessive open. Net new orders which peakedincreased 61% and 12% in the first quarter of 2022 at approximately 100 million pounds.
◦While open orders have declined over2024 versus the past year, Aluminum Extrusions has realized three sequential quartersfirst quarter of net booking growth.2023 and fourth quarter of 2023, respectively.
•EBITDA from ongoing operations for PE Films was $0.8$6.9 million in the secondfirst quarter of 2024 versus $1.8 million in the first quarter of 2023 versus $7.1and $4.5 million in the secondfourth quarter of 2022 as very weak conditions persisted2023. Sales volume was 10.0 million pounds in the consumer electronics market. EBITDA from ongoing operations duringfirst quarter of 2024 versus 7.4 million pounds in the last four quarters has been low with a rangefirst quarter of negative $2.62023 and 8.5 million to positive $1.8 million.pounds in the fourth quarter of 2023.
•EBITDA from ongoing operations for Flexible Packaging Films (also referred to as "Terphane") was $0.2$2.0 million during the secondfirst quarter of 2024 versus $1.4 million in the first quarter of 2023 versus $7.6and $2.3 million during the fourth quarter of 2023. Sales volume was 22.0 million pounds in the secondfirst quarter of 2022 primarily due to lower sales volume, which2024 versus 19.8 million pounds in the Company believes is mainly due to customer inventory corrections, lower marginsfirst quarter 2023 and unfavorable cost variances.
The Company recognized a net loss for the second quarter of 2023, with all business segments and their respective markets experiencing depressed conditions, which the Company believes can be traced to the residual impact of the pandemic.
The timing22.8 million pounds in the fourth quarter of recovery for our businesses remains uncertain and has been slow in occurring. Debt, net2023. See the Status of cash, declined during the quarter as a result of improvements in working capital, with further improvements anticipated by year end.
Other losses relatedAgreement to asset impairments and costs associated with exit and disposal activities were not material for the three and six months ended June 30, 2023 and 2022, respectively. Gains and losses associated with plant shutdowns, asset impairments, restructurings and other items are described Sell Terphane in Results of Operations below.below for information on the planned sale of Terphane.
The bottom of the recent severe down cycle in Aluminum Extrusions, which the Company believes was a residual impact of the pandemic and started in the second half of 2022, appears to have occurred in the third quarter of 2023. Net new orders and sales volume have increased sequentially in each quarter since that time. At PE Films, EBITDA from ongoing operations during the first quarter of 2024 was exceptional at $6.9 million. The process to complete the closing of the Company’s agreement to sell Terphane continues to advance as planned, including the review required by competition authorities in Brazil. The Company continues to focus on prudently managing costs, working capital and capital spending.
Results of Operations
SecondFirst Quarter of 20232024 Compared with the SecondFirst Quarter of 20222023
The following table presents a bridge of consolidated net income (loss) from the secondfirst quarter of 20222023 to the secondfirst quarter of 20232024 with management's related discussion and analysis below the table.
| | | | | | | | |
(In thousands) | | |
Net income (loss) for the three months ended June 30, 2022March 31, 2023 | | $ | 14,869 (1,009) | |
Income tax expense (benefit) | | 5,556331 | |
Income (loss) before income taxes for the three months ended June 30, 2022March 31, 2023 | | 20,425 (678) | |
Increase (decrease)Change in income (loss) from increases (decreases) in the following items: | | |
Sales | | (96,196)(15,386) | |
Other income (expense), net | | (1,362)(272) | |
Total | | (97,558)(15,658) | |
Increase (decrease)Change in income (loss) from (increases) decreases in the following items: | | |
Cost of goods sold | | 64,82117,482 | |
Freight | | 3,837 (623) | |
Selling, general and administrative | | 1,973748 | |
Goodwill impairmentResearch and development | | (15,413)853 | |
Pension and postretirement benefits | | 3,364 | |
Interest expense | | (1,144) | |
Other | | (338)(399) | |
Total | | 54,88020,281 | |
Income (loss) before income taxes for the three months ended June 30, 2023March 31, 2024 | | (22,253)3,945 | |
Income tax expense (benefit) | | (3,331)657 | |
Net income (loss) for the three months ended June 30, 2023March 31, 2024 | | $ | (18,922)3,288 | |
Sales in the secondfirst quarter of 20232024 decreased by $96.2$15.4 million compared with the secondfirst quarter of 2022.2023. Net sales (sales less freight) in Aluminum Extrusions decreased $68.5$19.1 million, primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in prices to cover higher operating costs. Net sales in PE Films decreased $15.5increased $4.6 million, primarily due to continuing weak market demandvolume increases in both Surface Protection and unfavorable product mix.overwrap films. Net sales in Flexible Packaging Films decreased $8.4$1.4 million, primarily due to lower sales volume, lower selling prices fromthat the pass-through of lower resin costsCompany believes are driven by excess global capacity and stronger competition in Brazil, Latin America and the U.S., and unfavorable product mix.mix, partially offset by higher sales volume. For more information on net sales and volume, see the Segment Operations Review below.
Other income (expense), net was $(20) thousand in the secondfirst quarter of 20232024 decreased by $0.3 million compared to other income (expense), net of $1.3 million inwith the secondfirst quarter of 2022.2023. The change in other income (expense), net iswas primarily due to cash consideration of $1.4$0.3 million received in May 2022January 2023 related to the customary post-closing adjustments on the sale of the investment in kaleo, Inc. ("kaléo"), which was sold in December 2021. See Note 5 for additional information.
Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 9.9%15.4% in the secondfirst quarter of 20232024 compared to 16.5%13.4% in the secondfirst quarter of 2022.2023. The gross profit margin in Aluminum Extrusions decreasedremained consistent with the prior year period primarily due to lower sales volume, offset by higher net pricing after the pass-through of metal costs changes, lower labor and employee-related costs, lower labor productivity, lower pricing and higher supply expense, associated with inflationary costs, partially offset by lower utility costsexpense and lower freight rates.expense. Additionally, the timing of the flow through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at higher prices in a quickly changing commodity pricing environment, resulted in a charge of $1.3$1.2 million in the secondfirst quarter of 20232024 versus a chargebenefit of $1.6$1.7 million in the secondfirst quarter
of 2022.2023. The gross profit margin in PE Films decreased primarilyincreased due to a lowerhigher Surface Protection contribution margin associated with a market slowdown, customer inventory corrections and the pass-through lag associated with resin costs, partially offset by overwrap filmshigher volume, favorable pricing, operating efficiencies and mix.manufacturing costs savings, lower fixed costs and cost improvements from overwrap films. The gross profit margin in Flexible Packaging Films decreasedslightly increased primarily due to lower selling prices from the pass-through ofraw material costs, lower resinfixed costs and margin pressures, lowerhigher sales volume, higher fixed costs, higher variable costs and unfavorable product mix, partially offset by lower raw materialselling prices from global excess capacity and margin pressures and higher variable costs.
As aThe percentage of sales, selling, general and administrative (“SG&A”) and research and development ("R&D") expenses were 10.3%of 10.6% in the secondfirst quarter of 2023 compared with 7.5% in the second quarter of 2022. While second quarter SG&A expenses and sales decreased year-over-year, R&D expenses2024 remained relatively consistent with the prior year period. Lower SG&A spending is primarilyfirst quarter of 2023.
During 2023, the Company settled the pension plan, which decreased the pension and other postretirement expenses for the first quarter of 2024 compared to the first quarter of 2023. See Note 4 for additional information.
Interest expense of $3.5 million in the first three months of 2024 increased $1.1 million compared to the first three months of 2023 due to lower accrualshigher average debt levels and interest rates. See Note 10 for employee-related compensation and lower stock-based compensation, partially offset by higher professional fees associated with business development activities.
In the second quarter of 2023, a non-cash partial goodwill impairment of $15.4 million was recognized, see the PE Films section in Segment Operations Review below for moreadditional information.
The effective tax rate used to compute income taxes forwas 16.7% in the secondfirst quarter of 2023 was 15.0%,2024 compared to 27.3%(48.8)% in the secondfirst quarter of 2022. The change in the effective tax rate is primarily due to a pre-tax loss in the three months ending June 30, 2023 versus pre-tax income in the three months ending June 30, 2022, lower Brazil tax incentives and a discrete charge in the second quarter of 2023 for a Brazil tax law change.2023. See Note 98 for additional information.
Pre-tax gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the secondfirst quarters of 20232024 and 20222023 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment table in Note 109 and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the condensed consolidated statements of income, unless otherwise noted. | | Three Months Ended March 31, | | | Three Months Ended March 31, |
(In millions) | | (In millions) | 2024 | 2023 |
Aluminum Extrusions: | |
| | | Three Months Ended June 30, |
(In millions) | 2023 | 2022 |
Aluminum Extrusions: | |
(Gains) losses from sale of assets, investment writedowns and other items: | (Gains) losses from sale of assets, investment writedowns and other items: | |
Storm damage to the Newnan, Georgia plant2 | $ | (0.2) | | $ | — | |
| (Gains) losses from sale of assets, investment writedowns and other items: | |
| (Gains) losses from sale of assets, investment writedowns and other items: | |
Consulting expenses for ERP/MES project1 | |
Consulting expenses for ERP/MES project1 | |
Consulting expenses for ERP/MES project1 | |
Storm damage to the Newnan, Georgia plant1 | |
Legal fees associated with the Aluminum Extruders Trade Case1 | |
Total for Aluminum Extrusions | Total for Aluminum Extrusions | $ | (0.2) | | $ | — | |
PE Films: | PE Films: | |
(Gains) losses from sale of assets, investment writedowns and other items: | |
COVID-19-related expenses1 | $ | — | | $ | 0.1 | |
Goodwill impairment | 15.4 | | — | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
| Richmond, Virginia Technical Center closure expenses, including severance3 | |
| Richmond, Virginia Technical Center closure expenses, including severance3 | |
| Richmond, Virginia Technical Center closure expenses, including severance3 | |
Richmond, Virginia Technical Center lease abandonment3 | |
| Total for PE Films | Total for PE Films | $ | 15.4 | | $ | 0.1 | |
| Total for PE Films | |
| Corporate: | |
Total for PE Films | |
Flexible Packaging Films: | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | (Gains) losses associated with plant shutdowns, asset impairments and restructurings: | |
Other restructuring costs - severance | Other restructuring costs - severance | $ | — | | $ | 0.1 | |
Other restructuring costs - severance | |
Other restructuring costs - severance | |
Total for Flexible Packaging Films | |
Corporate: | |
| (Gains) losses from sale of assets, investment writedowns and other items: | (Gains) losses from sale of assets, investment writedowns and other items: | |
Professional fees associated with business development activities2 | 1.6 | | 0.1 | |
Professional fees associated with remediation activities related to internal control over financial reporting2 | 0.5 | | 0.8 | |
Write-down of investment in Harbinger Capital Partners Special Situations Fund1 | 0.2 | | — | |
Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend2 | (0.1) | | (0.2) | |
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination3 | 3.4 | | 3.5 | |
| (Gains) losses from sale of assets, investment writedowns and other items: | |
| (Gains) losses from sale of assets, investment writedowns and other items: | |
Professional fees associated with business development activities1 | |
Professional fees associated with business development activities1 | |
Professional fees associated with business development activities1 | |
Professional fees associated with remediation activities related to internal control over financial reporting1 | |
Professional fees associated with the transition to the ABL Facility1 | |
| Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend1 | |
Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend1 | |
Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend1 | |
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination2 | |
| Total for Corporate | Total for Corporate | $ | 5.6 | | $ | 4.3 | |
1. Included in “Other income (expense), net” in the condensed consolidated statements of income. 2. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income. 3. See “Corporate Expenses, Interest, & Other” below and Note 4 for additional information. | Total for Corporate | |
Total for Corporate | |
1. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income. 2. See Note 4 for additional information. 3. See Note 1 for additional information. | | 1. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income. 2. See Note 4 for additional information. 3. See Note 1 for additional information. |
Average total debt outstanding and interest rates were as follows: | | | | | | | | | | | |
| Three Months Ended June 30, |
(In millions, except percentages) | 2023 | | 2022 |
Floating-rate debt with interest charged on a rollover basis plus a credit spread: | | | |
Average outstanding debt balance | $ | 150.0 | | | $ | 109.9 | |
Average interest rate | 6.9 | % | | 2.4 | % |
| | | | | | | | | | | |
| Three Months Ended March 31, |
(In millions, except percentages) | 2024 | | 2023 |
Floating-rate debt with interest charged on a rollover basis plus a credit spread: | | | |
Average total outstanding debt balance | $ | 153.1 | | | $ | 147.0 | |
Average interest rate | 9.4 | % | | 6.3 | % |
First Six Months of 2023 Compared with the First Six Months of 2022
The following table presents a bridge of consolidated net income (loss) from the first six months of 2022 to the first six months of 2023 with management's related discussion and analysis below the table.
| | | | | | | | |
(In thousands) | | |
Net income (loss) for the six months ended June 30, 2022 | | $ | 31,292 | |
Income tax expense (benefit) | | 6,334 | |
Income (loss) before income taxes for the six months ended June 30, 2022 | | 37,626 | |
Increase (decrease) in income from increases (decreases) in the following items: | | |
Sales | | (141,640) | |
Other income (expense), net | | (781) | |
Total | | (142,421) | |
Increase (decrease) in income from (increases) decreases in the following items: | | |
Cost of goods sold | | 88,556 | |
Freight | | 5,875 | |
Selling, general and administrative | | 4,249 | |
Goodwill impairment | | (15,413) | |
Other | | (1,406) | |
Total | | 81,861 | |
Income (loss) before income taxes for the six months ended June 30, 2023 | | (22,934) | |
Income tax expense (benefit) | | (3,000) | |
Net income (loss) for the six months ended June 30, 2023 | | $ | (19,934) | |
Sales in the first six months of 2023 decreased by $141.6 million compared with the first six months of 2022. Net sales (sales less freight) in Aluminum Extrusions decreased $93.2 million, primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in prices to cover higher operating costs. Net sales in PE Films decreased $26.5 million, primarily due to continuing weak market demand and unfavorable product mix. Net sales in Flexible Packaging Films decreased $16.1 million, primarily due to lower sales volume and lower selling prices from the pass-through of lower resin costs, partially offset by favorable product mix. For more information on net sales and volume, see the Segment Operations Review below.
Other income (expense), net was $0.3 million in the first six months of 2023 compared to other income (expense), net of $1.0 million in the first six months of 2022. The change in other income (expense), net is primarily due to cash consideration of $0.3 million received in January 2023 compared to $1.4 million received in May 2022 related to the customary post-closing adjustments on the sale of the investment in kaléo, which was sold in December 2021. See Note 5 for additional information.
Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 11.7% in the first six months of 2023 compared to 17.7% in the first six months of 2022. The gross profit margin in Aluminum Extrusions decreased primarily due to lower sales volume, higher labor and employee-related costs, lower labor productivity and higher supply expense, including higher paint expense associated with a shift to more painted product in the first quarter of 2023 and inflationary costs for other supplies, partially offset by higher pricing and lower utility costs. Additionally, the timing of the flow through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at lower prices in a quickly changing commodity pricing environment, resulted in a benefit of $0.4 million in the first six months of 2023 versus a benefit of $5.5 million in the first six months of 2022. The gross profit margin in PE Films decreased primarily due to a lower Surface Protection contribution margin for previously disclosed customer product transitions and for non-transitioning products associated with a market slowdown and customer inventory corrections, partially offset by favorable pricing and mix for overwrap films. The gross profit margin in Flexible Packaging Films decreased primarily due to lower sales volume, lower selling prices from the pass-through of lower resin costs and margin pressures, higher fixed costs, higher variable costs and unfavorable product mix, partially offset by lower raw material costs.
As a percentage of sales, SG&A and R&D expenses were 10.4% in the first six months of 2023, compared with 8.5% in the first six months of 2022. While first half SG&A expenses and sales decreased year-over-year, R&D expenses remained relatively consistent with the prior year period. Lower SG&A spending was primarily due to lower accruals for employee-related compensation and lower stock-based compensation, partially offset by higher professional fees associated with business development activities.
In the first half of 2023, a non-cash partial goodwill impairment of $15.4 million was recognized, see the PE Films section in Segment Operations Review below for more information.
The effective tax rate used to compute income taxes for the first six months of 2023 was 13.1%, compared to 16.9% in the first six months of 2022. The change in the effective tax rate is primarily due to a pre-tax loss in first six months of 2023 versus pre-tax income in first six months of 2022, lower Brazil tax incentives, a discrete charge in the second quarter of 2023 for a Brazil tax law change and a large discrete benefit recorded in the first quarter of 2022, resulting from the implementation of new U.S. tax regulations associated with foreign tax credits published by the U.S. Treasury and Internal Revenue Service on January 4, 2022. See Note 9 for additional information.
Pre-tax gains and losses associated with plant shutdowns, asset impairments, restructurings and other items for the first six months of 2023 and 2022 detailed below are shown in the statements of net sales and EBITDA from ongoing operations by segment table in Note 10 and are included in “Asset impairments and costs associated with exit and disposal activities, net of adjustments” in the condensed consolidated statements of income, unless otherwise noted. | | | | | | | | |
| Six Months Ended June 30, |
(In millions) | 2023 | 2022 |
Aluminum Extrusions: | | |
(Gains) losses from sale of assets, investment writedowns and other items: | | |
Storm damage to the Newnan, Georgia plant2 | $ | 0.4 | | $ | — | |
COVID-19-related expenses, net of relief1 | — | | 0.1 | |
Total for Aluminum Extrusions | $ | 0.4 | | $ | 0.1 | |
PE Films: | | |
(Gains) losses from sale of assets, investment writedowns and other items: | | |
COVID-19-related expenses1 | $ | — | | $ | 0.2 | |
Goodwill Impairment | 15.4 | | — | |
Total for PE Films | $ | 15.4 | | $ | 0.2 | |
Flexible Packaging Films: | | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | | |
Other restructuring costs - severance | $ | 0.1 | | $ | — | |
Total for Flexible Packaging Films | $ | 0.1 | | $ | — | |
Corporate: | | |
(Gains) losses associated with plant shutdowns, asset impairments and restructurings: | | |
Other restructuring costs - severance | $ | — | | $ | 0.1 | |
(Gains) losses from sale of assets, investment writedowns and other items: | | |
Professional fees associated with business development activities2 | $ | 1.9 | | $ | 1.6 | |
Professional fees associated with remediation activities related to internal control over financial reporting2 | 1.0 | | 1.2 | |
Write-down of investment in Harbinger Capital Partners Special Situations Fund1 | 0.2 | | — | |
Stock-based compensation expense associated with the fair value remeasurement of awards granted at the time of the 2020 special dividend2 | (0.2) | | (0.2) | |
Net periodic benefit cost for the frozen defined benefit pension plan in process of termination3 | 6.8 | | 6.9 | |
Total for Corporate | $ | 9.7 | | $ | 9.6 | |
1. Included in “Other income (expense), net” in the condensed consolidated statements of income. 2. Included in “Selling, general and administrative expenses” in the condensed consolidated statements of income. 3. See “Corporate Expenses, Interest, & Other” below and Note 4 for additional information. |
Average debt outstanding and interest rates were as follows: | | | | | | | | | | | |
| Six Months Ended June 30, |
(In millions, except percentages) | 2023 | | 2022 |
Floating-rate debt with interest charged on a rollover basis plus a credit spread: | | | |
Average outstanding debt balance | $ | 148.5 | | | $ | 106.9 | |
Average interest rate | 6.6 | % | | 2.1 | % |
Segment Operations Review
Aluminum Extrusions
A summary of results for Aluminum Extrusions is provided below: | | Three Months Ended | | Favorable/ (Unfavorable) % Change | | Six Months Ended | | Favorable/ (Unfavorable) % Change |
| Three Months Ended | |
| Three Months Ended | |
| Three Months Ended | |
(In thousands, except percentages) | (In thousands, except percentages) | June 30, | | Favorable/ (Unfavorable) % Change | | June 30, | | Favorable/ (Unfavorable) % Change |
2023 | | 2022 | | | | 2022 | |
(In thousands, except percentages) | |
| 2024 | |
2024 | |
Sales volume (lbs) | |
Sales volume (lbs) | |
Sales volume (lbs) | Sales volume (lbs) | 35,492 | | | 48,960 | | | (27.5)% | | 73,054 | | | 91,970 | | | (20.6)% |
Net sales | Net sales | $ | 121,827 | | | $ | 190,308 | | | (36.0)% | | $ | 255,197 | | | $ | 348,417 | | | (26.8)% |
Net sales | |
Net sales | |
Ongoing operations: | |
Ongoing operations: | |
Ongoing operations: | Ongoing operations: | |
EBITDA | EBITDA | $ | 10,217 | | | $ | 21,895 | | | (53.3)% | | $ | 24,855 | | | $ | 45,814 | | | (45.7)% |
EBITDA | |
EBITDA | |
Depreciation & amortization | |
Depreciation & amortization | |
Depreciation & amortization | Depreciation & amortization | (4,158) | | | (4,169) | | | 0.3% | | (8,569) | | | (8,430) | | | (1.6)% |
EBIT* | EBIT* | $ | 6,059 | | | $ | 17,726 | | | (65.8)% | | $ | 16,286 | | | $ | 37,384 | | | (56.4)% |
EBIT* | |
EBIT* | |
Capital expenditures | Capital expenditures | $ | 5,631 | | | $ | 3,989 | | | $ | 13,373 | | | $ | 6,870 | | |
*See the table in Note 10 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | Capital expenditures | |
Capital expenditures | |
*See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
*See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
*See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
SecondFirst Quarter 2024 Results vs. First Quarter 2023 Results vs. Second Quarter 2022 Results
Net sales (sales less freight) in the secondfirst quarter of 20232024 decreased 36.0% 14.4% versus the secondfirst quarter of 20222023 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in prices to cover higher operating costs. Sales volume in the secondfirst quarter of 2024 decreased 9.9% versus the first quarter of 2023 declined 27.5%but increased 2.7% versus the secondfourth quarter 2023.
Net new orders, which remain low compared to pre-pandemic levels but are growing, increased 61% in the first quarter of 2022. Nonresidential B&C sales volume, which represented 53% of 2022 volume, declined 23.8% in2024 versus the secondfirst quarter of 2023, versusmarking the second quartersixth consecutive quarterly increase in incoming orders. Since January 2021, net new orders for the Company's aluminum extruded products have generally tracked the ISM® Manufacturing PMI®. The Company believes that net new orders continue to be below pre-pandemic levels due to higher interest rates, tighter lender requirements and the increase in remote working, which particularly impacts the non-residential B&C end-use market. In addition, data indicates that aluminum extrusion imports increased significantly in recent years, especially during the pandemic, and some of 2022. Sales volume inBonnell Aluminum’s customers may have sourced, and continue to source, aluminum extrusions from producers outside the specialty market, which represented 29% of total volume in 2022, decreased 32.7% in the second quarter of 2023 versus the second quarter of 2022. Sales volume in the automotive market, which represented 8% of total volume in 2022, decreased 7.8% in the second quarter of 2023 versus the second quarter of 2022.United States.
Beginning in the third quarter of 2022, the Company observed slowing order input and order cancellations as customers continued to report high inventory levels, which carried into 2023. Open orders at the end of the secondfirst quarter of 2024 were 15 million pounds (versus 14 million pounds at the end of the fourth quarter of 2023 were 20 million pounds (versusand 27 million pounds at the end of the first quarter of 2023 and 86 million pounds at the end of the second quarter 2022)2023). This level is below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions (particularly starting in early 2021 with the re-opening of markets following the rollout of vaccines) that resulted in long lead times, driving a peak in open orders of approximately 100 million pounds during the first quarter of 2022.
The Company is participating as part of a coalition of members of the Aluminum Extruders Council who have filed a trade case with the Department of Commerce (“DOC”) and the U.S. International Trade Commission (“ITC”) against 15 countries in response to alleged large and increasing volumes of unfairly priced imports of aluminum extrusions since 2019. In addition, data indicatesNovember 2023, the ITC found that there is a reasonable indication that the American aluminum extrusions industry is materially injured or threatened with injury due to imports from 14 countries, including China. The ITC’s preliminary determination found that subject import volumes were significant and increasing, and that with regard to pricing, subject imports predominantly undersold the domestic product by volume in each year of the period of investigation. On May 2, 2024, the DOC announced its preliminarily determination that aluminum extrusion imports have increased significantlyproducers and exporters in recent years, and some of Bonnell Aluminum’s customers may have sourced, and continue to source,14 countries, including China,sold aluminum extrusions from producers outside ofat less-than-fair value in the United States. The Company is closely monitoringFinal determinations, which are expected by the situation and is prepared to work with the U.S. Government to ensure a fairly traded market. Nonetheless, Bonnell Aluminum has experienced three sequential quartersend of net booking growth. Net bookings were 16.9, 19.0, 20.4 and 28.2 million pounds in the third quarter of 2022 through the second quarter of 2023, respectively.2024, should provide an additional opportunity for Bonnell to regain market share.
EBITDA from ongoing operations in the secondfirst quarter of 2024 decreased $2.1 million versus the first quarter of 2023 decreased $11.7 million or 53.3% versus the second quarter of 2022 primarily due to:
•Lower volume ($11.93.3 million) offset by higher net pricing after the pass-through of metal cost changes ($2.0 million), higherlower labor and employee-related costs ($0.70.6 million), lower labor productivitysupply expense ($0.50.6 million), lower pricingutility expense ($1.0 million) and higher supply expense associated with inflationary costs ($0.8 million), partially offset by lower utility costs ($1.00.4 million), lower freight ratesSG&A expenses ($0.3 million) and lower SG&A expensesfreight rates ($1.60.2 million); and
•The timing of the flow-through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at higher prices in a quickly changing commodity pricing environment, resulted in a charge of $1.3 million in the second quarter of 2023 versus a charge of $1.6 million in the second quarter of 2022.
First Six Months of 2023 Results v. First Six Months of 2022 Results
Net sales in the first six months of 2023 decreased 26.8% versus the first six months of 2022 primarily due to lower sales volume and the pass-through of lower metal costs, partially offset by an increase in prices to cover higher operating costs. Sales volume in the first six months of 2023 decreased by 20.6% versus the first six months of 2022.
EBITDA from ongoing operations in the first six months of 2023 decreased $21.0 million or 45.7% in comparison to the first six months of 2022 primarily due to:
•Lower volume ($16.1 million), higher labor and employee-related costs ($2.4 million), lower labor productivity ($1.0 million) and higher supply expense, including higher paint expense associated with a shift to more painted product in
the first six months of 2023, and inflationary costs for other supplies ($3.0 million), partially offset by higher pricing ($5.6 million), lower utility costs ($0.6 million) and lower SG&A expenses ($0.8 million); and
•The timing of the flow-through under the first-in first-out method of aluminum raw material costs passed through to customers, previously acquired at lower prices in a quickly changing commodity pricing environment, resulted in a benefit of $0.4$1.2 million in the first six monthsquarter of 20232024 versus a benefit of $5.5$1.7 million in the first six monthsquarter of 2022.2023.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in this Form 10-Q for additional information on aluminum prices.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Bonnell Aluminum are projected to be $19$9 million in 2023 versus2024, including $4 million for productivity projects and $5 million for capital expenditures required to support continuity of operations. The projected spending reflects stringent spending measures that the previously disclosed projection of $26 million. The Company has implemented stringent spending measures to control its financial leverage (see “Net Debt, Financial Leverage and Debt Covenants” section for more information). In this regard, Bonnell Aluminum has reduced projected capital expenditures in the second half of 2023 to $5 million to mainly support continuity of current operations versus broader spending of $14 million during the first half of the year.leverage. The most significant reduction relates to the multi-year implementation offor new enterprise resource planning and manufacturing execution systems ("ERP/MES"). This project is being has been reorganized with an extended implementation period that increases the utilization of existing dedicated internal resources over a longer period in place of more costly external consultants.period. As a result, the earliest “go-live”"go-live" date for the newnet ERP/MES is likely in 2025. The ERP/MES project commenced in 2022, with spending to-date of approximately $21 million. Depreciation expense is projected to be $15$16 million in 2023.2024. Amortization expense is projected to be $2 million in 2023.2024.
PE Films
A summary of results for PE Films is provided below: | | Three Months Ended | | Favorable/ (Unfavorable) % Change | | Six Months Ended | | Favorable/ (Unfavorable) % Change |
| Three Months Ended | |
| Three Months Ended | |
| Three Months Ended | |
(In thousands, except percentages) | (In thousands, except percentages) | June 30, | | Favorable/ (Unfavorable) % Change | | June 30, | | Favorable/ (Unfavorable) % Change |
2023 | | 2022 | | | | 2022 | |
(In thousands, except percentages) | |
| 2024 | |
2024 | |
Sales volume (lbs) | |
Sales volume (lbs) | |
Sales volume (lbs) | Sales volume (lbs) | 6,245 | | | 9,639 | | | (35.2)% | | 13,613 | | | 20,192 | | | (32.6)% |
Net sales | Net sales | $ | 15,918 | | | $ | 31,424 | | | (49.3)% | | $ | 36,099 | | | $ | 62,555 | | | (42.3)% |
Net sales | |
Net sales | |
Ongoing operations: | |
Ongoing operations: | |
Ongoing operations: | Ongoing operations: | |
EBITDA | EBITDA | $ | 814 | | | $ | 7,065 | | | (88.5)% | | $ | 2,663 | | | $ | 14,112 | | | (81.1)% |
EBITDA | |
EBITDA | |
Depreciation & amortization | |
Depreciation & amortization | |
Depreciation & amortization | Depreciation & amortization | (1,552) | | | (1,559) | | | 0.4% | | (3,195) | | | (3,154) | | | (1.3)% |
EBIT* | EBIT* | $ | (738) | | | $ | 5,506 | | | (113.4)% | | $ | (532) | | | $ | 10,958 | | | (104.9)% |
EBIT* | |
EBIT* | |
Capital expenditures | Capital expenditures | $ | 360 | | | $ | 1,163 | | | $ | 1,075 | | | $ | 1,744 | | |
* See the table in Note 10 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | Capital expenditures | |
Capital expenditures | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. ** Not meaningful ("NM") | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. ** Not meaningful ("NM") | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. ** Not meaningful ("NM") | |
SecondFirst Quarter 2024 Results vs. First Quarter 2023 Results vs. Second Quarter 2022 Results
Net sales in the secondfirst quarter of 2024 were 22.6% higher compared to the first quarter of 2023, decreased 49.3% compared to the secondwith volume quarter of 2022. Sales volume in the second quarter of 2023 decreasedincreases in both Surface Protection and overwrap films versus the second quarter of 2022.films. Surface Protection sales volume in the secondfirst quarter of 2023 declined 54.2% versus the second quarter of 2022 and 26.9%2024 increased 43% versus the first quarter of 2023 and 30% versus the fourth quarter of 2023. Given recent volume improvements for Surface Protection sales continue to be adversely impacted by weakand other market demand forindicators, the Company believes that the consumer electronics which beganmarket is now in recovery mode.
EBITDA from ongoing operations during the thirdfirst quarter of last year. Manufacturers in2024 was $6.9 million, which was exceptional and well above comparable amounts realized during the supply chain are experiencing reduced capacity utilizationsecond and inventory corrections. In addition, these market conditions are adversely impacting mix through reduced sales to our highest value-added customers. The timingfirst halves of a recovery in Surface Protection remains uncertain.2023 of $8.6 million and $2.7 million, respectively.
EBITDA from ongoing operations in the secondfirst quarter of 20232024 increased $5.1 million decreased $6.3 million versus the secondfirst quarter of 2022,2023, primarily due to:
•A $7.7$4.4 million decreaseincrease from Surface Protection:
◦Protection primarily due to hLowerigher contribution margin associated with a market slowdownhigher volume ($1.0 million), favorable pricing ($0.3 million), operating efficiencies and customer inventory correctionsmanufacturing costs savings ($8.61.9 million), partially offset bylower fixed costs ($0.4 million), and lower SG&A and operating efficiencies ($0.7 million); and
◦The pass-through lagmillion, including $0.6 million associated with resin costs ($0.1 million chargethe closure of the Richmond Technical Center in the second quarter of 2023 versus a charge of $0.3 million in the second quarter of 2022)2023).
•A $1.4 $0.7 million increase from overwrap films primarily due to cost improvements.
First Six Months of 2023 Results v. First Six Months of 2022 Results
Net sales in the first six months of 2023 decreased 42.3% compared to the first six months of 2022 primarily due to a decrease in sales volume in Surface Protection, as a result of the factors noted above. Sales volume declined 45.4% in Surface Protection in the first six months of 2023.
EBITDA from ongoing operations in the first six months of 2023 decreased by $11.4 million versus the first six months of 2022, primarily due to:
•A $12.6 million decrease from Surface Protection:
◦Lower contribution margin for non-transitioning products associated with a market slowdown and customer inventory corrections ($12.7 million) and for previously disclosed customer product transitions ($0.7 million), partially offset by lower SG&A and other employee-related expenses and operating efficiencies ($1.2 million); and
◦The pass-through lag associated with resin costs ($0.2 million charge in the second quarter of 2023 versus a benefit of $0.2 million in the second quarter of 2022).
•A $1.1 million increase from overwrap films primarily due to cost improvements ($1.5 million), partially offset by the pass-through lag associated with resin costs (a charge of $0.2 million in the first six months of 2023 versus a benefit of $0.2 million in the first six months of 2022).
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in this Form 10-Q for additional information on resin prices.
Closure of PE Films Technical Center
On August 3, 2023, the Company adopted a plan to close the PE Films technical center in Richmond, VA and reduce its efforts to develop and sell films supporting the semiconductor market. Future research & development activities for PE Films will be performed at the facility in Pottsville, PA. PE Films continues to have new business opportunities primarily relating to surface protection films that protect components of flat panel and flexible displays. The Company anticipates all activities to cease at the PE Films technical center in Richmond, VA, by the end of 2023. The Company expects to recognize cash costs associated with exit activities of $1.8 million for: (i) severance and related costs ($0.9 million), (ii) vacating the facility lease ($0.6 million payable through June 2025), and (iii) building closure costs ($0.3 million). In addition, the Company expects non-cash asset write-offs and accelerated depreciation of up to $4.5 million. Net annual cash savings of $3.4 million are anticipated, beginning in the fourth quarter of 2023.
Goodwill Impairment in Surface Protection
Manufacturers in the supply chain for consumer electronics continue to experience reduced capacity utilization and inventory corrections. In light of the continued uncertainty about the timing of a recovery for this market and the expected adverse future impact to the Surface Protection business, the Company performed a goodwill impairment analysis of the Surface Protection component of PE Films using projections that contemplate the expected market recovery and business conditions. The analysis concluded that the fair value of Surface Protection was less than its carrying value, thus a non-cash partial goodwill impairment of $15.4 million ($11.9 million after deferred income tax benefits) was recognized during the second quarter of 2023.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for PE Films are projected to be $3$2 million in 2023,2024, including $1 million for productivity projects and $2$1 million for capital expenditures required to support continuity of current operations. Depreciation expense is projected to be $6$5 million in 2023.2024. There is no amortization expense for PE Films.
Flexible Packaging Films
A summary of results for Flexible Packaging Films is provided below: | | Three Months Ended | | Favorable/ (Unfavorable) % Change | | Six Months Ended | | Favorable/ (Unfavorable) % Change |
| Three Months Ended | |
| Three Months Ended | |
| Three Months Ended | |
(In thousands, except percentages) | (In thousands, except percentages) | June 30, | | Favorable/ (Unfavorable) % Change | | June 30, | | Favorable/ (Unfavorable) % Change |
2023 | | 2022 | | | | 2022 | |
(In thousands, except percentages) | |
| 2024 | |
2024 | |
Sales volume (lbs) | |
Sales volume (lbs) | |
Sales volume (lbs) | Sales volume (lbs) | 23,724 | | | 27,315 | | | (13.1)% | | 43,569 | | | 53,321 | | | (18.3)% |
Net sales | Net sales | $ | 33,223 | | | $ | 41,595 | | | (20.1)% | | $ | 64,750 | | | $ | 80,839 | | | (19.9)% |
Net sales | |
Net sales | |
Ongoing operations: | |
Ongoing operations: | |
Ongoing operations: | Ongoing operations: | |
EBITDA | EBITDA | $ | 249 | | | $ | 7,631 | | | (96.7)% | | $ | 1,599 | | | $ | 12,665 | | | (87.4)% |
EBITDA | |
EBITDA | |
Depreciation & amortization | |
Depreciation & amortization | |
Depreciation & amortization | Depreciation & amortization | (711) | | | (583) | | | (22.0)% | | (1,411) | | | (1,132) | | | (24.6)% |
EBIT* | EBIT* | $ | (462) | | | $ | 7,048 | | | (106.6)% | | $ | 188 | | | $ | 11,533 | | | (98.4)% |
EBIT* | |
EBIT* | |
Capital expenditures | Capital expenditures | $ | 878 | | | $ | 3,264 | | | $ | 1,483 | | | $ | 4,809 | | |
* See the table in Note 10 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | Capital expenditures | |
Capital expenditures | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
* See the table in Note 9 for a reconciliation of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP. | |
SecondFirst Quarter 2024 Results vs. First Quarter 2023 Results vs. Second Quarter 2022 Results
Net sales in the secondfirst quarter of 20232024 decreased 20.1%4.5% compared to the secondfirst quarter of 20222023 primarily due to lower sales volume, lower selling prices fromthat the pass-through of lower resin costsCompany believes are driven by excess global capacity and strong competition in Brazil, Latin America and the U.S., and unfavorable product mix. The Company believes that lowermix, partially offset by higher sales volume was primarily due to customer inventory corrections. While sales volume in the second quarter of 2023 was still below expected normalized levels, it improved 20% over the first quarter of the year.volume.
EBITDA from ongoing operations in the secondfirst quarter of 2023 decreased $7.42024 increased $0.6 million versus the secondfirst quarter of 2022,2023, primarily due to:
•Lower selling prices from the pass-through of lower resinraw material costs and margin pressures ($2.91.9 million), lower fixed costs ($1.7 million), higher sales volume ($1.9 1.0 million), higher fixed costs and lower SG&A ($1.1 million, primarily due to under absorption from lower production volumes), higher variable costs ($1.8 million, including higher costs resulting from quality issues and other costs associated with the shutdown of production lines to adjust production volumes to sales levels) and unfavorable product mix ($0.60.2 million), partially offset by lower raw materialselling prices from global excess capacity and margin pressures ($2.1 million) and higher variable costs ($1.3 million) and lower SG&A expenses ($0.1 million);
•Foreign currency transaction lossesgains ($0.20.1 million) in the secondfirst quarter of 20232024 compared to foreign currency transaction gainslosses ($0.60.1 million) in the secondfirst quarter of 2022;2023; and
•Net favorable foreign currency translation of Real-denominated operating costs ($0.2 million).
First Six Months of 2023 Results v. First Six Months of 2022 Results
Net sales in the first six months of 2023 decreased 19.9% compared to the first six months of 2022 primarily due to lower sales volume and lower selling prices from the pass-through of lower resin costs, partially offset by favorable product mix.
EBITDA from ongoing operations in the first six months of 2023 decreased $11.1 million versus the first six months of 2022 primarily due to:
•Lower sales volume ($4.9 million), lower selling prices from the pass-through of lower resin costs and margin pressures ($3.6 million), higher fixed costs ($2.1 million, primarily due to under absorption from lower production volumes), higher variable costs ($0.7 million, including higher costs resulting from quality issues) and unfavorable product mix ($1.3 million), partially offset by lower raw material costs ($1.6 million) and lower SG&A expenses ($0.1 million);
•Net unfavorable foreign currency translation of Real-denominated operating costs ($0.10.9 million); and.
•Foreign currency transaction losses ($0.2 million) in the second quarter of 2023 compared to foreign currency transaction losses ($0.3 million) in the second quarter of 2022.
Refer to Item 3. Quantitative and Qualitative Disclosures About Market Risk in this Form 10-Q for additional information on polyester fiber and component price trends.
Projected Capital Expenditures and Depreciation & Amortization
Capital expenditures for Flexible Packaging Films are projected to be $6$4 million in 2023, including $2 million for new capacity for value-added products and productivity projects and $4 million2024 for capital expenditures required to support continuity of current operations. Depreciation expense is projected to be $3 million in 2023.2024. Amortization expense is projected to be $0.1 million in 2023.2024.
Corporate Expenses, Interest & Other
Corporate expenses, net in the first sixthree months of 20232024 decreased $2.0$3.2 million compared to the first sixthree months of 20222023 primarily due to lower accruals for employee-related compensationpension expense as a result of the pension plan termination completed in 2023 ($2.13.4 million) and lower stock-based compensationinternal audit fees ($0.40.3 million), partially offset by higher professional fees associated with business development activitiesstock-based compensation ($0.6 million).
Interest expense of $4.7$3.5 million in the first sixthree months of 20232024 increased $2.7$1.1 million compared to the first sixthree months of 20222023 due to higher average debt levels and interest rates.
Pension expense under GAAPStatus of $6.8 million in the first six months of 2023 remained consistent with the first six months of 2022. In February 2022, Tredegar announced the initiation of a processAgreement to terminate and settle its frozen defined benefit pension plan. In connection therewith, the Company borrowed funds under its revolving credit agreement ("Credit Agreement") and made a $50 million contribution to the pension plan (the “Special Contribution”) to reduce its underfunding and as part of a program within the pension plan to hedge or fix the expected future contributions that will be needed by the Company through the settlement process. The funds borrowed for the Special Contribution were effectively made available with proceeds received in December 2021 from the sale of the Company’s investment in kaléo. In addition, the Company realized income tax cash benefits on the Special Contribution of $11 million in the fourth quarter of 2022.Sell Terphane
During the second quarter ofOn September 1, 2023, the Company receivedannounced that it had entered into a favorable IRS determination letter,definitive agreement to sell Terphane to Oben Group (the “Contingent Terphane Sale”). Completion of the sale is contingent upon the satisfaction of customary closing conditions, including the receipt of certain competition filing approvals by authorities in Brazil and government agencies andColombia. On October 27, 2023, the Company expectfiled the completionrequisite competition forms with the Administrative Council for Economic Defense (“CADE”) in
Brazil. The regulatory review process is ongoing and in line with the Company’s expectations. CADE’s maximum deadline for completing its review is no later than November 18, 2024. The merger review regarding the transaction was cleared by the Colombian authority in early February 2024.
As of March 31, 2024, the Company has reported results for Terphane as a continuing operation, given the status of the settlementapproval process on or about October 31, 2023. Administrative costs forby authorities. If the entire settlement process with respectsale transaction is completed, the Company expects to the pension plan are estimated at $4 to $5 million.
The estimated underfundingrealize after-tax net debt-free cash proceeds of Tredegar’s frozen defined benefit pension plan was approximately $30$85 million at June 30, 2023. As of December 31, 2022, the estimated underfunding of $28 million was comprised of investments at fair value of $218 millionafter deducting projected Brazil withholding taxes, escrow funds, U.S. capital gains taxes and a projected benefit obligation (“PBO”) of $246 million. GAAP accounting requires adjustment for changes in values of assets and the PBO only at the end of each year, even though these values change daily. The ultimate underfunded amount at settlementtransaction costs. Actual after-tax proceeds may differ from the current amounts, depending onestimates due to possible changes in market factors, including with respect to buyers of pension obligations atdeductions and the time of settlement.
PriorCompany's tax situation during the potentially lengthy interim period to the Special Contribution, GAAP pension expense was a reasonable proxy for the Company’s required minimum cash contribution to the pension plan. The Company estimates that, with the Special Contribution, there will be no required minimum cash contributions until final settlement. Pension expense under GAAP is projected to be approximately $14 million in 2023, which is mainly comprised of non-cash amortization of deferred net actuarial losses reflected in the Company’s shareholders’ equity as accumulated other comprehensive losses. Beginning in 2022, and consistent with no expected required minimum cash contributions, no pension expense is included in calculating earnings before interest, taxes, depreciation and amortization as defined in the Company’s revolving Credit Agreement ("Credit EBITDA").closing date.
Net capitalization and other credit measures are provided in Liquidity and Capital Resources below.
Liquidity and Capital Resources
The Company continues to focus on improving working capital management. Measures such as days sales outstanding (“DSO”), days inventory outstanding (“DIO”) and days payables outstanding (“DPO”) are used to evaluate changes in working capital. Changes in operating assets and liabilities from December 31, 20222023 to June 30, 2023March 31, 2024 are summarized below.
•Accounts and other receivables decreased $5.4increased $5.1 million (6.4%(7.5%).
◦Accounts and other receivables in Aluminum Extrusions decreased $6.8increased $7.3 million primarily due to lowerincreased sales volume andduring the pass-throughfirst three months of lower metal costs.2024. DSO (represents trailing 12 months net sales divided by a rolling 12-month average of accounts and other receivables balances) was approximately 48.943.9 days for the 12 months ended June 30, 2023March 31, 2024 and 48.745.1 days for the 12 months ended December 31, 2022.2023.
◦Accounts and other receivables in PE Films remained relatively flat. DSO was approximately 28.826.3 days for the 12 months ended June 30, 2023,March 31, 2024, which was lower compared to 30.3 daysthe same for the 12 months ended December 31, 2022 due to shorter customer repayment terms associated with sales of lower margin product during the second quarter of 2023.
◦Accounts and other receivables in Flexible Packaging Films increased $1.0decreased $2.3 million primarily due to sales to customers in 2023 that contain unfavorable terms.improved collection efforts during the three months ended 2024. DSO was approximately 39.037.1 days for the 12 months ended June 30, 2023March 31, 2024 and 41.138.1 days for the 12 months ended December 31, 2022.2023.
•Inventories decreased $41.1increased $4.8 million (32.2%(5.8%).
◦Inventories in Aluminum Extrusions decreased $23.9 million due to decreased raw material levels as a result of slowing order input and order cancellations as customers continue to report high inventory levels.remained relatively flat. DIO (represents trailing 12 months costs of goods sold calculated on a first-in first-out basis divided by a rolling 12-month average of inventory balances calculated on the first-in first-out basis) was approximately 57.548.3 days for the 12 months ended June 30, 2023March 31, 2024 and 53.651.6 days for the 12 months ended December 31, 2022.2023.
◦Inventories in PE Films decreased $2.3increased $2.9 million due to lowerhigher raw materials and finished goods for overwrap films.to support increased sales volume during the first three months of 2024. DIO was approximately 68.353.6 days for the 12 months ended June 30, 2023March 31, 2024 and 66.857.2 days for the 12 months ended December 31, 2022.2023.
◦Inventories in Flexible Packaging Films decreased $14.8increased $1.9 million primarily due to lowerhigher raw material purchases and lower finished goods levels as a result of lower sales volume.purchases. DIO was approximately 122.8107.8 days for the 12 months ended June 30, 2023March 31, 2024 and 108.0117.7 days for the 12 months ended December 31, 2022.2023.
•Net property, plant and equipment increased $3.5decreased $5.5 million primarily due to capital expendituresdepreciation expense of $14.5$6.3 million and a $1.7$0.9 million favorableunfavorable change in the value of the U.S. dollar relative to foreign currencies, partially offset by depreciation expensecapital expenditures of $12.4$1.8 million.
•Identifiable intangible assets, net decreased $0.9$0.5 million (7.7%(4.9%) due to amortization expense.
•Deferred income tax assets increaseddecreased $0.7 million primarily due to changes in other comprehensive income, increase in net operational losses, and a decrease in the deferred tax liability related to the goodwill impairment.(2.9%). See Note 98 for additionalmore information.
•Accounts payable decreased $32.6$10.1 million (28.4%(10.6%).
◦Accounts payable in Aluminum Extrusions decreased $21.2$9.0 million primarily due to lower raw material purchases and favorable vendor terms.the timing of payments. DPO (represents trailing 12 months costs of goods sold calculated on a first-in first-out basis divided by a rolling 12-month average of accounts payable balances) was approximately 56.847.7 days for the 12 months ended June 30, 2023March 31, 2024 and 64.249.8 days for the 12 months ended December 31, 2022.2023.
◦Accounts payable in PE Films remained relatively flat.increased $2.7 million primarily due to higher raw material purchases. DPO was approximately 43.9 days for the 12 months ended June 30, 2023March 31, 2024 and 51.043.4 days for the 12 months ended December 31, 2022.2023.
◦Accounts payable in Flexible Packaging Films decreased $11.4$3.8 million primarily due to lower raw material purchases.costs. DPO was approximately 64.365.3 days for the 12 months ended June 30, 2023March 31, 2024 and 72.461.7 days for the 12 months ended December 31, 2022.2023.
Net cash provided by operating activities was $22.7 million in the first six months of 2023 compared to net cash used in operating activities of $9.4was $7.7 million in the first sixthree months of 2022.2024 compared to $9.1 million in the first three months of 2023. The change in operating activities isdecrease was primarily due to the Special Contribution ($50 million) and improved working capital due to factors discussed earlier in this section relating to accounts and other receivables, inventories and accounts payable.
Net cash used in investing activities was $15.6$2.4 million in the first sixthree months of 20232024 compared to net cash used in investing activities of $12.1$8.8 million the first sixthree months of 2022.2023. The increasedecrease was primarily due to higherlower capital expenditures ($2.46.6 million), partially offset by cash consideration of $0.3 million received in January 2023 compared to $1.4 million received in the May 2022 related to the customary post-closing adjustments on the sale of the investment in kaléo, which was sold in December 2021..
Net cash used in financing activities was $4.9 million in the first six months of 2023, compared to net cash provided by financing activities of $18.7was $2.0 million in the first sixthree months of 2022.2024, compared to $13.6 million in the first three months of 2023. The change in financing activitiesdecrease was primarily due to
lower net borrowings ($24.516.0 million) under the Credit AgreementABL Facility (as defined below) during the first sixthree months of 20232024 as compared to the first sixthree months of 2022 when2023 and dividends paid ($4.4 million) during the Company borrowed funds and made a $50 million Special Contribution to the pension plan in February 2022 and lower deferred financing costs ($1.2 million).
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditures and debt repayments for at least the next twelve months. In the longer term, liquidity will depend on many factors, including resultsfirst three months of operations, the timing and extent of capital expenditures, changes in operating plans or other events that would cause the Company to seek additional financing in future periods.2023.
At June 30, 2023,March 31, 2024, the Company had cash, and cash equivalents and restricted cash of $21.2$4.8 million, including cash and cash equivalents held in locations outside the U.S. of $13.9$3.8 million.
As of June 30,Debt and Credit Agreements
ABL Facility
On December 27, 2023, Tredegar hadthe Company entered into Amendment No. 3 (the “ABL Facility”) to the Second Amended and Restated Credit Agreement, which provides the Company with a five-year,$180 million senior secured asset-based revolving secured credit facility that permits aggregate borrowings of $375 million and matureswill expire on June 29, 2027.
Net capitalization30, 2026. On April 16, 2024, the Company entered into Amendment No. 4 (the "Amendment") that, among other items: (i) moves the ABL Adjustment Date (defined below) from March 31, 2025 to September 30, 2025 and indebtedness as defined under the Credit Agreement as of June 30, 2023 were as follows: | | | | | |
Net Capitalization and Indebtedness as of June 30, 2023 |
(In thousands) |
Net capitalization: | |
Cash and cash equivalents | $ | 21,193 | |
Debt: | |
Credit Agreement | 141,000 | |
Debt, net of cash and cash equivalents | 119,807 | |
Shareholders’ equity | 183,149 | |
Net capitalization | $ | 302,956 | |
Indebtedness as defined in Credit Agreement: | |
Total debt | $ | 141,000 | |
Indebtedness | $ | 141,000 | |
Borrowings under the Credit Agreement bear an interest rate equal to SOFR plus a credit spread adjustment of 10 basis points ("Adjusted Term SOFR Rate") and an amount depending on the type of borrowing and commitment fees charged on the unused amount under the Credit Agreement at various Total Net Leverage Ratio levels as follows: | | | | | | | | |
Pricing Under the Credit Agreement (Basis Points) |
Total Net Leverage Ratio | Term Benchmark Spread | Commitment Fee |
<= 1.0x | 150.0 | | 20 | |
>1.0x but <=2.0x | 162.5 | | 25 | |
>2.0x but <=3.0x | 175.0 | | 30 | |
>3.0x but <=3.5x | 187.5 | | 35 | |
>3.5x | 200.0 | | 40 | |
At June 30, 2023, $141.0 million(ii) requires weekly reporting of the outstanding debt was principally priced at an interest rate equal to the Adjusted Term SOFR Rate plus the applicable credit spread of 175.0 basis points.
borrowing base financial covenant. The primary financial restrictive covenants in the Credit Agreement include:
•Total Net Leverage Ratio of 4.00x;
•Interest Coverage Ratio of 3.00x; and
•Unlimited payments for dividends and stock repurchases during the term of the Credit Agreement so long as the Total Net Leverage Ratio is equal to or less than 2.00x, and otherwise restrictions on payments for dividends and stock repurchases for the term of the Credit Agreement at $75 million (provided that the $75 million basket will reset at the end of each fiscal quarter when the Total Net Leverage ratio is less than or equal to 2.00x).
Under the Credit Agreement:
•Total Net Leverage Ratio is defined as the ratio of (a)(i) total indebtedness minus (ii) liquidity (the lesser of $50,000,000 and the aggregate amount of cash and cash equivalents) to (b) Credit EBITDA; and
•Interest Coverage Ratio is defined as the ratio of Credit EBITDA to interest expense.
The Credit AgreementABL Facility is secured by substantially all assets of the Company’sCompany and its domestic subsidiaries’ assets,subsidiaries, including equity in certain material first-tier foreign subsidiaries. At June 30, 2023, based upon the restrictive covenants within the Credit Agreement, available creditAvailability for borrowings under the Credit AgreementABL Facility is governed by a borrowing base, determined by the application of specified advance rates against eligible assets, including a portion of trade accounts receivable, inventory, cash and cash equivalents, owned real properties, and owned machinery and equipment. Upon the earlier of September 30, 2025 or the date the Company receives the proceeds from the sale of Terphane (the “ABL Adjustment Date”), the $180 million ABL Facility will be reduced to $125 million. As of March 31, 2024, availability under the ABL Facility was approximately $33 million. Total debt$22.2 million, after reducing the borrowing base by the aggregate outstanding was $141.0borrowings of $128.3 million, standby letters of credit of $13.1 million, and $137.0 million as of June 30, 2023 and December 31, 2022, respectively.
Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and should not be considered as an alternative to either net income (loss) or to cash flow. The computations of Credit EBITDA, the Total Net Leverage Ratio and Interest Coverage Ratio asMinimum Liquidity (as defined in the ABL Facility) financial covenant.
Under the terms of the ABL Facility, certain domestic bank accounts are subject to blocked account agreements, each of which contains a springing feature whereby the lenders may exercise control over those accounts during a cash dominion period (any such period, a “Cash Dominion Period”). A Cash Dominion Period was implemented on the date of the closing of the ABL Facility and will remain in effect at all times prior to the ABL Adjustment Date. After the ABL Adjustment Date, a Cash Dominion Period goes into effect if availability under the ABL Facility falls below 12.5% or an Event of Default (as defined in the ABL Facility) occurs. The Company would then be subject to the Cash Dominion Period until the Event of Default is waived or ABL Facility availability is above 12.5% of the $125 million aggregate commitment for 30 consecutive days. Receipts that have not yet been applied to the ABL Facility are classified as restricted cash in the Company’s consolidated balance sheets.
The financial covenants in the ABL Facility are as follows:
•Until the ABL Adjustment Date, the Company is required to maintain (i) a minimum Credit Agreement are presented below.EBITDA (as defined in the ABL Facility), as of the end of each fiscal month for the 12-month period then ended (presented below) and (ii) a Minimum Liquidity (as defined in the ABL Facility) of $10.0 million.
| | | | | |
Minimum Credit EBITDA (In thousands) |
March 2024 | $ | 16,640 | |
April 2024 | 19,780 | |
May 2024 | 19,660 | |
June 2024 | 19,450 | |
July 2024 | 21,860 | |
August 2024 | 22,830 | |
September 2024 | 25,370 | |
October 2024 | 26,070 | |
November 2024 | 27,640 | |
December 2024 | 29,640 | |
January 2025 | 29,740 | |
February 2025 | 29,850 | |
March 2025 | 29,980 | |
April 2025 | 30,340 | |
May 2025 | 30,700 | |
June 2025 | 31,030 | |
July 2025 | 31,370 | |
August 2025 | 31,710 | |
September 2025 | $ | 32,080 | |
•Following the ABL Adjustment Date, the foregoing financial covenants will cease to exist and will be replaced with a minimum fixed charge coverage ratio of 1.00:1.00 that will be triggered in the event that availability is less than 10% of $125 million commitment amount and continuing thereafter until availability is greater than 10% of the $125 million commitment amount for 30 consecutive days.
The computation of Credit EBITDA, as defined in the ABL Facility, is presented below. | | | | | |
Computations of Credit EBITDA Total Net Leverage Ratio and Interest Coverage Ratio (in each case, as Defined(as defined in the Credit Agreement) Along with Related Primary Restrictive CovenantsABL Facility) as of and for the Twelve Months Ended June 30, 2023March 31, 2024 * |
ComputationComputations of Credit EBITDA for the twelve months ended June 30, 2023 (In Thousands)March 31, 2024 (in thousands): |
Net income (loss) | $ | (22,772)(101,608) | |
Plus: | |
After-tax losses related to discontinued operations | — | |
Total income tax expense for continuing operations | — | |
Interest expense | 7,65612,751 | |
Depreciation and amortization expense for continuing operations | 26,89427,554 | |
All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $6,399)$9,899) | 22,002141,252 | |
Charges related to stock option grants and awards accounted for under the fair value-based method | 773— | |
Losses related to the application of the equity method of accounting | — | |
Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | — | |
Fees, costs and expenses incurred in connection with the amendment process | 184 | |
Terphane sale transaction costs in an amount not to exceed $10,000 | 4,949 | |
Minus: | |
After-tax income related to discontinued operations | (27)— | |
Total income tax benefits for continuing operations | (4,945)(53,799) | |
Interest income | (99)(500) | |
All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings | — | |
Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method | — | |
Income related to the application of the equity method of accounting | — | |
Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting | (262)— | |
Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period | — | |
Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions | — | |
Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early payment of pension obligations | 14,2647,284 | |
Credit EBITDA | $38,067 | | 43,484 |
Computations of Total Net Leverage Ratio*Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and Interest Coverage Ratio at June 30, 2023:
|
Total Net Leverage Ratio | 2.76x |
Interest Coverage Ratio | 5.68x |
Primary restrictive covenants: | |
Unlimited payments for dividends and stock repurchases during the term of the Credit Agreement so longshould not be considered as the Total Net Leverage Ratio is equalan alternative to either net income (loss) or less than 2.00x, and otherwise restrictions on payments for dividends and stock repurchases for the term of the Credit Agreement at $75 million | $to cash flow. | 75,000 | |
Maximum Total Net Leverage Ratio permitted | 4.00x |
Minimum Interest Coverage Ratio permitted | 3.00x |
The Company had Credit EBITDAcomputation of the ABL Facility availability and a Total Net Leverage RatioMinimum Liquidity covenant, as defined in the ABL Facility, is presented below. | | | | | | | | | | | |
(In thousands, except percentages) | March 31, 2024 | | December 31, 2023 |
| | | |
Maximum aggregate principal | $ | 180,000 | | | $ | 180,000 | |
| | | |
Maximum borrowing limit per the Borrowing base as defined in the ABL Facility (includes eligible domestic cash and cash equivalents of $851 as of March 31, 2024 and $3,846 as of December 31, 2023) | $ | 173,601 | | | $ | 172,286 | |
ABL Facility outstanding debt (matures on June 30, 2026) | 128,330 | | | 126,322 | |
Outstanding standby letters of credit | 13,080 | | | 13,080 | |
ABL Facility availability | $ | 32,191 | | | $ | 32,884 | |
Minimum Liquidity covenant | 10,000 | | | 10,000 | |
ABL Facility availability in excess of Minimum Liquidity covenant | $ | 22,191 | | | $ | 22,884 | |
In addition to the financial covenants, the ABL Facility contains restrictive covenants, including covenants that restrict the Company’s ability to pay dividends and repurchase shares of $43.5 million and 2.76x, respectively, at June 30, 2023, which had significantly deteriorated fromits common stock.
As of March 31, 2024, the Credit EBITDA and Total Net Leverage Ratio at December 31, 2022 of $84.4 million and 1.39x, respectively.
TredegarCompany was in compliance with all debt covenants.
Terphane Brazil Loan
On October 26, 2023, Terphane Ltda., the Company’s wholly owned subsidiary in Brazil, borrowed $20 million secured by certain of its debt covenants as of Juneassets (“Terphane Brazil Loan”). This U.S. Dollar borrowing matures on October 30, 2023. Noncompliance with any2028. The Company expects that the Terphane Brazil Loan will be repaid (and collateral released) upon the closing of the debt covenants could have a material adverse effect on its financial condition or liquidity, in the event such noncompliance cannot be cured or shouldContingent Terphane Sale. On October 26, 2023, the Company be unableborrowed $20 million from Terphane Ltda. (the “Intercompany Loan”) at the same interest rate as the Terphane Brazil Loan, thereby transferring the funds to obtain a waiver from the lenders. RenegotiationU.S. The Company will repay the Intercompany Loan in conjunction with the closing of the covenant through an amendmentContingent Terphane Sale.
For more information on the ABL Facility and the Terphane Brazil Loan, see Note 10 for additional information.
The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, and debt repayments for at least the Credit Agreement could effectively curenext 12 months. In the noncompliance, but could have an effectlonger term, liquidity will depend on its financial conditionmany factors, including the results of operations, the timing and extent of capital expenditures, changes in operating plans, or liquidity depending upon howother events that would cause the covenant is renegotiated.Company to seek additional financing in future periods. In addition, the Company’s projections indicate further deteriorationcompletion of the Total Net Leverage Ratio without paying dividends to between 4.0x and 5.0x through the quarter ending March 31, 2024.
Subsequent to June 30, 2023, the Company amended the Credit Agreement. To reduce the risk of potential violations of the primary financial restrictive covenants in the Credit Agreement while the Company's businesses and markets are experiencing a downturn, the Company (i) suspended its regular quarterly dividend (which had an annual cash outlay of approximately $17.7 million) and (ii) amended the Credit Agreement, effective August 3, 2023, to:
a.Change the fiscal quarter maximum Total Net Leverage Ratio covenant from 4.0x to: (i) 5.0x for the quarters ending September 30, 2023 through March 31, 2024, (ii) 4.75x for the quarter ending June 30, 2024, (iii) 4.25 for the quarter ending September 30, 2024, and (iv) 4.0x for the quarter ending December 31, 2024 and thereafter.
b.Change the fiscal quarter minimum Interest Coverage Ratio covenant from 3.0x to: (i) 2.50x for the quarters ending September 30, 2023 through June 30, 2024, (ii) 2.75x for the quarter ending September 30, 2024, and (iii) 3.0x for the quarter ending December 31, 2024 and thereafter.
c.Reduce the maximum borrowing availability from $375 million to $200 million.
d.Increase the drawn spread by 25 basis points across all levels of the interest rate pricing grid, beginning the quarter ending September 30, 2023.
e.Amend the restricted payments covenant to prohibit dividends and share repurchases during fiscal quarters ending September 30, 2023 through December 31, 2024.
To further decrease the risk of a debt covenant violation during a severe cyclical downturn, the Company is investigating the replacement of the existing EBITDA-based credit facility by the end of 2023 with other financing alternatives, including borrowings thatContingent Terphane Sale would be permitted based on the level of secured receivables, inventories and machinery and equipment and sale and leaseback of existing Company-owned property.provide additional liquidity.
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Tredegar has exposure to the volatility of interest rates, polyethylene and polypropylene resin prices, Terephthalic Acid (“PTA”) and Monoethylene Glycol (“MEG”) prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See Liquidity and Capital Resources above regarding interest rate exposures related to borrowings under the Credit Agreement.
Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices and the timing of those changes could have a significant impact on profit margins in PE Films. Changes in polyester resin, PTA and MEG prices, and the timing of those changes, could have a significant impact on profit margins in Flexible Packaging Films. There is no assurance of the Company’s ability to pass through higher raw material and energy costs to its customers.
The purchase price of raw materials fluctuates on a monthly basis; therefore, Aluminum Extrusions pricing policies generally allow the Company to pass the underlying index cost of aluminum and certain alloys through to the vast majority of our customers so that we remain substantially neutral to metal pricing. In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 87 for additional information.
The volatility of quarterly average aluminum prices is shown in the chart below.
| | |
Source: Quarterly averages computed by the Company using daily Midwest average prices provided by Platts. |
The volatility of quarterly average natural gas prices is shown in the chart below.
| | |
Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices. |
The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films) is shown in the chart below.
| | |
Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2019. In January 2023, IHS reflected a 41 cents per pound non-market adjustment based on their estimate of the growth of discounts in the prior periods. The 4th quarter 2022 average rate of $0.60 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2022. |
The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in resin prices are not passed through for a period of 90 days. In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, Tredegar Surface Protection implemented a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such arrangements. Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets that the Company competes.
Polyester resins, MEG and PTA used in flexible packaging films produced in Brazil are primarily purchased domestically, with other sources available mostly from Asia and the U.S. Given the nature of these products as commodities, pricing is derived from Asian pricing indexes. The volatility of the average quarterly prices for polyester fibers in Asia, which is representative of polyester resin (a primary raw material for Flexible Packaging Films) pricing trends, is shown in the chart below:
| | |
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data.
|
The volatility of average quarterly prices of PTA and MEG in Asia (raw materials used in the production of polyester resins produced by Flexible Packaging Films) is shown in the chart below:
| | |
Source: Quarterly averages computed by Tredegar using monthly data from CMAI Global Index data. |
Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of foreign currencies and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global environment (for additional information, see trends for the Brazilian Real and Chinese Yuan in the charts on the following page). Exports from the U.S. are generally denominated in U.S. Dollars. The Company’s foreign currency exposure on income from foreign operations relates to the Chinese Yuan and the Brazilian Real.
PE Films is generally able to match the currency of its sales and costs for its product lines. For flexible packaging films produced in Brazil, selling prices and key raw material costs are principally determined in U.S. Dollars and are impacted by local economic conditions and local and global competitive dynamics. Flexible Packaging Films is exposed to foreign
exchange translation risk (its functional currency is the Brazilian Real) because almost 90% of the sales of Flexible Packaging Films business unit in Brazil (“Terphane Ltda.”) and substantially all of its related raw material costs are quoted or priced in U.S. Dollars while its variable conversion, fixed conversion and sales, general and administrative costs before depreciation & amortization (collectively “Terphane Ltda. Operating Costs”) are quoted or priced in Brazilian Real. This mismatch, together with a variety of economic variables impacting currency exchange rates, causes volatility that could negatively or positively impact EBITDA from ongoing operations for Flexible Packaging Films.
The Company estimates annual net costs of R$177139.0 million for the net mismatch translation exposure between Terphane Ltda.’s U.S. Dollar quoted or priced sales and raw material costs and underlying Brazilian Real quoted or priced Terphane Ltda. Operating Costs. Terphane Ltda. has outstanding foreign exchange average forward rate contracts to purchase Brazilian Real and sell U.S. Dollars to hedge its exposure. See Note 87 for more information on outstanding hedging contracts and this hedging program.
Tredegar estimates that the change in the value of foreign currencies relative to the U.S. Dollar for PE Films had no impact on EBITDA from ongoing operations for the secondfirst quarter of 2023 and an unfavorable impact on EBITDA from ongoing operations of $0.1 million in the first half of 20232024 compared with the same periodsperiod of 2022.2023.
Trends for the Brazilian Real and Chinese Yuan exchange rates relative to the U.S. Dollar are shown in the chart below.
| | |
Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.
|
Item 4. Controls and Procedures.
On November 1, 2018, the Company filed a Current Report on Form 8-K (the “November 2018 Form 8-K”) to disclose certain material weaknesses in internal control over financial reporting. For further information, see the November 2018 Form 8-K and Item 4. “Controls and Procedures” of the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2018.
As of December 31, 2022, the results of management’s testing of the design, implementation and operating effectiveness of controls identified that the Company continued to have material weaknesses in its internal control over financial reporting; however, the material weaknesses existing as of December 31, 2022 were limited to certain discrete items within the previously identified material weaknesses. As a result, management revised its original six step remediation plan that was designed with the assistance of management’s outside consultant, an internationally recognized accounting firm. As of June 30, 2023, the Company continues to execute its revised remediation plan, including the implementation of the new and revised internal controls over financial reporting.
Evaluation of Disclosure Controls and Procedures
In connection with the preparation of this Form 10-Q, pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Company carried out an evaluation with the participation of its management, including its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of June 30, 2023.
Based on this evaluation of our disclosure controls and procedures as of March 31, 2024, the Company’sCompany's Chief Executive Officer and Chief Financial Officer concluded that, becauseas of the material weaknesses in internal control over financial reporting discussed below, the Company’ssuch date, our disclosure controls and procedures were not effective as of June 30, 2023, to ensure: (i) that information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and (ii) that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Management’s Report on Internal Control Over Financial Reporting
The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control over financial reporting is a process designed by or under the supervision of the Company’s Chief Executive Officer and Chief Financial Officer, and overseen by the Board of Directors, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes policies and procedures that:
a.Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;
b.Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with the authorization of its management and directors; and
c.Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of the Company’s consolidated financial statements would be prevented or detected. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.
Management conducted an evaluation of the effectiveness of the Company’s internal control over financial reporting using the criteria in Internal Control - Integrated Framework 2013 issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “2013 COSO Framework”). Based on management’s assessment, the Company’s Chief Executive Officer and Chief Financial Officer concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2022. The Company did not sufficiently attract, develop, and retain competent resources to fulfill internal control responsibilities and did not have an effective information and communication process that identified and assessed the source of and controls necessary to ensure the reliability of information used in financial reporting. As a consequence of these material weaknesses, the Company did not effectively design, implement and operate process-level controls across its financial reporting processes.
While these material weaknesses did not result in material misstatements of the Company’s consolidated financial statements as of and for the year ended December 31, 2022, these material weaknesses create a reasonable possibility that a material misstatement of account balances or disclosures in annual or interim consolidated financial statements may not be prevented or detected in a timely manner. Accordingly, the Company concluded that the deficiencies represent material weaknesses in its internal control over financial reporting and its internal control over financial reporting was not effective as of December 31, 2022.
The Company’s independent registered public accounting firm, KPMG LLP, which audited the 2022 consolidated financial statements included in the 2022 Form 10-K, expressed an adverse opinion on the operating effectiveness of the Company's internal control over financial reporting.
Remediation Plan and Efforts to Address the Identified Material Weaknesses
To remediate the material weaknesses described above, the Company, with the oversight of the Audit Committee of the Board of Directors (the “Audit Committee”), has been pursuing the revised remediation plan to implement new and revised internal controls over financial reporting.
Through the second quarter of 2023, the Company has completed certain steps in its revised remediation plan, including:
a.Conducted interviews with relevant parties and confirmed management’s understanding of the internal control activities, including information used in the recording of transactions within the Company's financial reporting processes;
b.Completed a comprehensive review and update to the documentation of relevant processes with respect to the Company’s internal control over financial reporting;
c.Developed internal control remediation plans to enhance controls for deficiencies associated with the material weaknesses above, including an assessment of personnel skills and experience related to the design and operation of internal control activities;
d.Substantially implemented all new and revised internal controls to address the previously identified deficiencies associated with the material weaknesses above;
e.Expanded the internal control compliance department with personnel that have appropriate internal control experience and identified resources for positions relevant to internal controls that had previously experienced turnover; and
f.Executed a targeted training program to educate control owners on the requirements of internal control activities, including maintaining adequate documentary evidence for internal control activities.
The design and implementation of certain new and revised internal controls associated with expenditure and revenue processes for one remaining manufacturing location of the Aluminum Extrusion business is scheduled for completion in the third quarter of 2023.
The material weaknesses cannot be considered remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. The Company is committed to the improvement of its internal control over financial reporting and management continues to work with its outside consultant to assist in those efforts, as necessary. The Company continues to monitor the impact of employee turnover and other external factors on its remediation plan and its assessment of internal control over financial reporting. The Company cannot assure you when it will remediate the identified material weaknesses, nor can it be certain whether additional actions will be required. Moreover, the Company cannot assure you that additional material weaknesses will not arise in the future.effective.
Changes in Internal Control Over Financial Reporting
The Company is in the process of implementing certain changes in its internal controls to remediate the material weaknesses described above. Except as noted above, thereThere has been no change in the Company’s internal control over financial reporting during the quarter ended June 30, 2023,March 31, 2024, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).
PART II - OTHER INFORMATION
Item 1A. Risk Factors.
As disclosed in “Item 1A. Risk Factors” in the 20222023 Form 10-K, there are a number of risks and uncertainties that can have a material effect on the operating results of our businesses and our financial condition. Except as set forth below, thereThere are no material updates or changes to our risk factors previously disclosed in the 20222023 Form 10-K.
Further impairment of the Surface Protection reporting unit’s goodwill could have a material non-cash adverse impact on our results of operations. The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). The valuation of goodwill depends on a variety of factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as Company and reporting unit factors, and goodwill impairment valuations can be sensitive to assumptions associated with such factors. Failure to successfully achieve projections could result in future impairments.Manufacturers in the supply chain for consumer electronics continue to experience reduced capacity utilization and inventory corrections. In light of the continued uncertainty about the timing of a recovery for this market and the expected adverse future impact to the Surface Protection business, as of June 30, 2023 the Company performed a goodwill impairment analysis of the Surface Protection component of PE Films using projections that contemplate the expected market recovery and business conditions. The analysis concluded that the fair value of Surface Protection was less than its carrying value, thus a non-cash partial goodwill impairment of $15.4 million ($11.9 million after deferred income tax benefits) was recognized during the second quarter of 2023.
Further impairment to the Surface Protection reporting unit’s goodwill may be caused by factors outside the Company’s control, such as increasing competitive pricing pressures, continued weak consumer electronic market demand, lower than expected sales and profit growth rates, and various other factors. Significant and unanticipated changes could require an
additional non-cash charge for impairment in a future period, which may significantly affect the Company’s results of operations in the period of such charge.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The Company’s Credit Agreement contains financial and other restrictive covenants, including a restriction on the Company’s ability to pay dividends to shareholders. For more information on the Credit Agreement, see “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources.”
Item 5. Other Information.
Director and Officer Trading Arrangements
During the three months ended June 30, 2023,March 31, 2024, no director or officer of the Company adopted terminated or modifiedterminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.
Entry into a Material Definitive Agreement
On August 3, 2023, the Company, as borrower, entered into Amendment No. 2 (the “Second Amendment”) to the Second Amended and Restated Credit Agreement with the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (collectively, the “Lenders”).
The following sets forth a description of the material terms of the Second Amendment:
a.Changed the fiscal quarter maximum Total Net Leverage Ratio covenant from 4.0x to: (i) 5.0x for the quarters ending September 30, 2023 through March 31, 2024, (ii) 4.75x for the quarter ending June 30, 2024, (iii) 4.25 for the quarter ending September 30, 2024, and (iv) 4.0x for the quarter ending December 31, 2024 and thereafter.
b.Changed the fiscal quarter minimum Interest Coverage Ratio covenant from 3.0x to: (i) 2.50x for the quarters ending September 30, 2023 through June 30, 2024, (ii) 2.75x for the quarter ending September 30, 2024, and (iii) 3.0x for the quarter ending December 31, 2024 and thereafter.
c.Reduced the maximum borrowing availability from $375 million to $200 million.
d.Increased the drawn spread by 25 basis points across all levels of the interest rate pricing grid, beginning the quarter ending September 30, 2023.
e.Amended the restricted payments covenant to prohibit dividends and share repurchases during fiscal quarters ending September 30, 2023 through December 31, 2024.
The Company and its affiliates regularly engage the Lenders to provide other banking services. All of these engagements are negotiated at arm’s length.
The foregoing description of the Second Amendment is not complete and is qualified in its entirety by reference to the entire Second Amendment, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Closure of PE Films Technical Center
On August 3, 2023, the Company adopted a plan to close the PE Films technical center in Richmond, VA and reduce its efforts to develop and sell films supporting the semiconductor market. Future research & development activities for PE Films will be performed at the facility in Pottsville, PA. PE Films continues to have new business opportunities primarily relating to surface protection films that protect components of flat panel and flexible displays. The Company anticipates all activities to cease at the PE Films technical center in Richmond, VA, by the end of 2023. The Company expects to recognize cash costs associated with exit activities of $1.8 million for: (i) severance and related costs ($0.9 million), (ii) vacating the facility lease ($0.6 million payable through June 2025), and (iii) building closure costs ($0.3 million). In addition, the Company expects non-cash asset write-offs and accelerated depreciation of up to $4.5 million. Net annual cash savings of $3.4 million are anticipated, beginning in the fourth quarter of 2023.
Item 6. Exhibits. | | | | | | | | |
10.1 | | Amendment No. 14, dated April 16, 2024, to the Second Amended and Restated Credit Agreement, dated as of NovemberJune 29, 2022, by and among Tredegar Corporation, as borrower, certain of Tredegar Corporation’s material domestic subsidiaries, as guarantors, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents (filed as Exhibit 10.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on April 22, 2024, and the other lenders party thereto.incorporated herein by reference). |
*10.2 | | Amendment No. 2 to Second AmendedForm of Notice of Phantom Stock Unit Award and Restated Credit Agreement, dated as of August 3, 2023, among Tredegar Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A.Phantom Stock Unit Award Terms and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto.Conditions. |
31.1 | | |
31.2 | | |
32.1 | | |
32.2 | | |
101 | | XBRL Instance Document and Related Items. |
104 | | Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101). |
* | | Denotes compensatory plans or arrangements or management contracts. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. | | | | | | | | | | | | | | |
| | | | Tredegar Corporation |
| | | | (Registrant) |
| | |
Date: | | AugustMay 9, 20232024 | | /s/ John M. Steitz |
| | | | John M. Steitz |
| | | | President and Chief Executive Officer |
| | | | (Principal Executive Officer) |
| | | | |
Date: | | AugustMay 9, 20232024 | | /s/ D. Andrew Edwards |
| | | | D. Andrew Edwards |
| | | | Executive Vice President and Chief Financial Officer |
| | | | (Principal Financial Officer) |
| | | | |
Date: | | AugustMay 9, 20232024 | | /s/ Frasier W. Brickhouse, II |
| | | | Frasier W. Brickhouse, II |
| | | | Corporate Treasurer and Controller |
| | | | (Principal Accounting Officer) |